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Abstract 
The ubiquitin-dependent proteolytic pathway plays an important role in a broad 
array of ce1lular processes, inducting ce11 cyc1e control and transcription. Biochemical 
analysis of the ubiquitination of Sic 1, the B-type cyc1in-dependent kinase (CDK) 
inhibitor in budding yeast helped to define a ubiquitin ligase complex named SCFcdc4 (for 
S.kp 1, Cdc53/cu11in, E-box protein). We found that besides Sic I, the CDK inhibitor Farl 
and the replication initiation protein Cdc6 are also substrates of SCFcdc4 in vitro. A 
common feature in the ubiquitination of the ce11 cyc1e SCFcdc4 substrates is that they must 
be phosphorylated by the major ce11 cyc1e CDK, Cdc28. Gcn4, a transcription activator 
involved in the general control of amino acid biosynthesis, is rapidly degraded in an 
SCFcdc4-dependent manner in vivo. We have focused on this substrate to investigate the 
generality of the SCFcdc4 pathway. Through biochemical fractionations, we found that the 
Srb 10 CDK phosphorylates Gcn4 and thereby marks it for recognition by scpCdc4 
ubiquitin ligase. Srb 10 is a physiological regulator of Gcn4 stability because both 
phosphorylation and turnover of Gcn4 are diminished in srbl 0 mutants. Furthermore, we 
found that at least two different CDKs, Pho85 and Srb 10, conspire to promote the rapid 
degradation of Gcn4 in vivo. The multistress response transcriptional regulator Msn2 is 
also a substrate for Srbl 0 and is hyperphosphorylated in an Srb I 0-dependent manner 
upon heat stress-induced translocation into the nuc1eus. Whereas Msn2 is cytoplasmic in 
resting wild type cells, its nuc1ear exc1usion is partia11y compromised in srblO mutant 
ce11s. Srb 10 has been shown to repress a subset of genes in vivo, and has been proposed 
to inhibit transcription via phosphorylation of the C-terminal domain of RNA polymerase 
II. Our results suggest a general theme that Srb 10 represses the transcription of specific 
genes by directly antagonizing the transcriptional activators. 
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The Ubiquitin-Proteasome Pathway 
Overview 
Precise modulation of intracellular protein concentrations is both necessary and 
sometimes critical as cells switch from one state to another in response to diverse 
environmental stimuli or the regulated developmental programs. Cells achieve this 
through various regulatory mechanisms such as transcriptional, translational, and post-
translational means. Among these, selective protein degradation presents advantages 
over the other regulatory controls. First of all, protein degradation allows rapid 
achievement of new steady-state level of a protein after the change in the rate of its 
synthesis. Second, degradation provides an irreversible means of inactivating or 
removing the protein. Although this mechanism of regulation of protein levels appears 
energy-consuming because cells have to resynthesize the destroyed proteins, only a small 
percentage of the cellular proteins, mostly key regulatory proteins, undergo constitutive 
or timing-based turnover. 
Proteolysis was original regarded as a means by which a cell eliminates aberrant 
or damaged proteins. In the past decade, there have been ever increasing examples that 
establish the importance of protein degradation in cellular regulation. There exist several 
proteolytic pathways in the cytoplasm of eukaryotic cells. The major pathway that 
degrades proteins is the ubiquitin-dependent degradation pathway (Hershko and 
Ciechanover 1998). This pathway targets proteins to degradation by the 26S proteasome 
via covalent attachment of multi-ubiquitin chains (a process commonly referred to as 
"ubiquitination"). Ubiquitination of substrate proteins is a multistep process that 
generally requires three classes of enzymes: the El ubiquitin-activating enzyme, the E2 
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ubiquitin-conjugating enzyme, and the E3 ubiquitin ligase. Multiubiquitin chains are 
thought to serve as signals for recognition and breakdown of protein substrates by the 
multi-subunit and ATP-dependent protease complex called 26S proteasome. To date, 
ubiquitin-mediated degradation has been shown to play important roles in a broad array 
of cellular processes, including cell cycle transitions, signal transduction, immune 
response and inflammation, development and differentiation, and transcriptional 
regulation. 
Ubiquitin 
Ubiquitin is a small, highly conserved globular protein consisting of 76 amino 
acids. Yeast and human ubiquitin differ by only three amino acids. It was originally 
isolated from the thymus (Goldstein et al. 1975), but was found later to be present 
ubiquitously in all tissues and organisms. The first evidence of ubiquitin attachment to 
other proteins came in 1977, when the C-terminus of ubiquitin was found to be 
covalently linked via isopeptide bond to the epsilon-amino group of the lysine residue of 
histone 2A (Goldknopf and Busch 1977). The functional link between ubiquitin and 
protein degradation was not established until ubiquitin was found to be required for the 
ATP-dependent proteolytic activity in fractionated reticulocyte lysates and was found to 
be conjugated to protein substrates (Ciechanover et al. 1978; Ciechanover et al. 1980; 
Wilkinson et al. 1980). These and other findings led Hershko and coworkers to propose 
that ubiquitin attachment to proteins serves as a signal that marks them for degradation by 
a protease (Hershko et al. 1980). Although monoubiquitination has been observed on 
several proteins, its role appears to be unrelated to targeting protein for degradation. 
Recent developments indicate that monoubiquitination is involved in distinct cellular 
functions such as histone regulation, endocytosis, and the budding of retroviruses from 
the plasma membrane (Ricke 2001 ). The existence of multiubiquitin chains linked via 
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lysine 48 (K48) of ubiquitin was first demonstrated in 1989 (Chau et al. 1989). Inhibition 
of proteolysis by selective expression of K48R mutant ubiquitin led to the proposal that 
proteolytic targeting is primarily achieved through multiubiquitin chains assembled via 
K48 linkages (Finley et al. 1994). 
Ubiquitin-activating enzyme (El) 
Following the discovery of ubiquitin attachment to proteins, Hershko and 
coworkers identified three enzymatic activities (E1, E2, and E3) required for 
ubiquitination (Ciechanover et al. 1981 ; Hershko et al. 1983). E 1 is the first enzyme in 
this multistep process, and it catalyzes the activation of ubiquitin. This reaction proceeds 
in an A TP-dependent manner, resulting in the formation of a high-energy thioester bond 
between the C-terminal glycine residue of ubiquitin and a specific cysteine residue in the 
E 1 enzyme. This thioester bond is labile, and ubiquitin is subsequently transferred to the 
ubiquitin-conjugating enzyme (E2) via transesterification. Most eukaryotes have one 
major functional El enzyme. In budding yeastS. cerevisiae, UBAJ encodes the only El 
enzyme and is essential for cell viability (McGrath et al. 1991 ). E I enzymes are 
abundant and present in both the cytoplasm and nucleus. 
Ubiquitin-conjugating enzyme (E2) 
Ubiquitin-conjugating enzymes (also called UBCs or ubiquitin carrier proteins) represent 
the second class of enzymes in the ubiquitin-conjugation pathway, An E2 accepts the 
ubiquitin molecule from the E1 enzyme by forming a thioester bond between an active-
site cysteine residue and the ubiquitin. This allows ubiquitin to be further transferred 
either directly to a substrate or to the ubiquitin ligase (E3) via another transesterification. 
The E2 enzymes form a relative large class of enzymes in the ubiquitin-conjugation 
system, consisting of at least 30 enzymes, including 13 in budding yeast. They are 
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relatively small molecules (ranging from 16 to 34 kDa in budding yeast) and are 
structurally related, consisting of a highly conserved (35-40% identity) 16 kDa catalytic 
domain called the UBC domain (Jentsch 1992). Within this domain lies a specific 
cysteine residue required for E2-ubiquitin thioester formation. Although E2 enzymes in 
budding yeast have been implicated to play important roles in DNA repair, stress 
response, membrane protein turnover, cell cycle progression, and transcription (Scheffner 
et al. 1998), only CDC34 is essential. 
Two relatively well-characterized E2 enzymes in budding yeast are Rad6 (Ubc2) 
and Cdc34 (Ubc3). RAD6 encodes a 172 amino acid, 20 kDa protein containing the 
conserved UBC domain (Jentsch et al. 1987). Mutation of RAD6 leads to pleiotropic 
phenotypes, including slow growth, sensitivity to DNA damaging agents, deficiency in 
UV -induced mutagenesis, increased retrotransposition, and sporulation defects 
(Lawrence 1994). Some evidence suggests that the role of Rad6 in DNA repair may be 
mediated through ubiquitin-dependent degradation (Bailly et al. 1994 ). Early studies in 
the Varshavsky laboratory have shown that ubiquitination of certain proteins by the so-
called "N-end rule" pathway (Bachmair et al. 1986; Varshavsky 1992) requires Rad6, 
which physically associates with the E3 enzyme called Ubr 1 (Dohmen et al. 1991 ; 
Madura et al. 1993). Recent in vitro reconstitution experiments have shown that Rad6 
promotes the multi-ubiquitination of a homeodomain-containing protein Cup9 (Turner et 
al. 2000). Interestingly, Rad6 has also been implicated in the turnover of the 
transcription factor Gcn4. Gcn4 is partially stabilized in a rad611 mutant, but not ubrl 11 
(Kornitzer et al. 1994). In vitro ubiquitination experiments using fractionated yeast 
extracts suggest that Rad6 promotes the ubiquitination of Gcn4 (Y. Chi and R. Deshaies, 
unpublished data). It appears that Rad6 is involved in the ubiquitination of a variety of 
proteins and may associate with distinct E3 enzymes. 
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CDC34 is an essential gene originally identified in a screen for cell division cycle 
or cdc mutants. Temperature-sensitive mutants of CDC34 arrest in G 1 phase of the cell 
cycle. The biochemical function of Cdc34 remained obscure until the discovery of its 
sequence similarity to Rad6 (Goebl et al. 1988). The realization that Cdc34 is a 
ubiquitin-conjugating enzyme provided an important clue on the biological trigger at the 
G 1 to S phase transition. Genetic analysis identified the B-type cyclin-Cdk inhibitor Sic 1 
as a key physiological substrate of Cdc34 and thus implicated the role of proteolysis in 
G 1 to S phase transition (Schwob et al. 1994). CDC34, along with other genes (CDC53 
and CDC4), which are also required for Sic 1 degradation, defines a ubiquitination 
pathway that was initially named the "CDC34 pathway" (Deshaies 1995). Besides Sic 1, 
several other proteins are stabilized in a cdc341s mutant, suggesting that they are potential 
CDC34 pathway substrates. These include the G 1 cyclins Cln2 (Deshaies et al. 1995) 
and Cln3 (Yaglom et al. 1995), G 1 cyclin-Cdk inhibitor Far I (Henchoz et al. 1997), 
replication initiation protein Cdc6 (Drury et al. 1997), and transcription activator Gcn4 
(Kornitzer et al. 1994). The evidence that Gcn4, a transcription factor involved in the up-
regulation of amino acid and purine biosynthesis, is degraded in Cdc34-dependent 
manner suggests that CDC34 pathway is not confined to cell cycle targets. 
The functions of other UBCs in budding yeast are less well characterized. Ubc4 
and Ubc5 are needed for the degradation of many short-lived and abnormal proteins 
(Hochstrasser 1996). Ubc6 and Ubc7, along with Ubc4 and Ubc5, are required for the 
rapid degradation of the Mata2 repressor (Chen et al. 1993). Ubc9's role has been 
controversial. It was originally found to be required for cell cycle transition at the G2 or 
early M phase and for the degradation of B-type cycl ins, suggesting that Ubc9 
participates in the ubiquitination of B-type cyclins (Seufert et al. 1995). Recent evidence, 
however, indicates that Ubc9 promotes the conjugation of a yeast ubiquitin-like protein 
6 
Smt3 (or mammalian SUMO-I), and therefore suggests that Ubc9 may affect cyclin 
degradation indirectly (Schwarz et al. 1998). 
Ubiquitin ligase (E3) 
Ubiquitin ligases (or ubiquitin protein ligases) are the third and least understood 
component of the ubiquitination machinery. Although E2 enzymes can directly transfer 
the ubiquitin to substrates in some instances without E3 (Haas et al. 199 1 ), they generally 
require E3 for efficient attachment of ubiquitin to substrate prote ins. Ubiquitin ligases 
are particularly important because they are widely regarded as the substrate-recognition 
components of the ubiquitination machinery that confer specificity and regulation. They 
were initially defined as activities that bind to E2 and substrates, and stimulate 
ubiquitination reactions in the presence of E 1 and E2 (Hershko and Ciechanover 1992). 
The discovery of E3s has been slow because, unlike E2s, they do not share easily 
identifiable sequence motifs. Furthermore, recent evidence suggests that E3 activities 
may be comprised of multi-protein complexes in addition to single subunit ligases. Early 
studies have identified two distinct families of ubiquitin ligases. They are the yeast Ubr1 
(or mammalian homolog E3a) and the hect (homologous to E6-AP ~arboxyl-terminus) 
domain family defined by E6-associated protein (E6-AP). E6-AP was discovered as a 
100 kDa ce11ular protein that is required, along with papillomavirus E6 oncoprotein, for 
the ubiquitination and degradation of p53 in reticulocyte lysates (Scheffner et al. 1993). 
Ubrl and E6-AP appear mechanistically distinct in their actions. Whereas Ubr1 binds 
substrates and stimulates the reactions catalyzed by E2 by a poorly understood 
mechanism (Bartel et al. 1990), E6-AP catalyzes the ubiquitin transfer through an E 1-E2-
E3 enzyme ubiquitin thioester cascade, in which formation of the ubiquitin-E6-AP 
thioester intermediate is an obligatory step (Scheffner et al. 1995). The budding yeast 
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genome encodes five hect-domain proteins, and one of them, Rsp5, has been shown to 
ubiquitinate the largest subunit of RNA polymerase II in vitro (Huibregtse et al. 1997). 
Yeast Ubr1 (mammalian counterpart is called E3a) is a non-essential , 225 kDa 
protein. It is the key component of theN-end rule pathway, which relates the half-life of 
a protein to its N-terminal residues (Bachmair et al. 1986; Varshavsky 1992; Varshavsky 
et al. 2000). Although theN-end rule recognition mechanism is conserved in eukaryotes, 
its primary physiological roles and substrates are still not fully understood. The first 
physiological function of Ubr1 has been shown to be the regulation of peptide uptake 
(Alagramam et al. 1995) by mediating the degradation of the homeodomain 
transcriptional repressor Cup9 (Byrd et al. 1998). Recent biochemical evidence shows 
that E1 , Rad6, and Ubr1 ubiquitinates Cup9 in vitro, and ubiquitination of Cup9 is 
enhanced by dipeptides bearing destabilizing N-terminal residues (Turner et al. 2000). 
Advances in cell cycle studies in the past few years have helped to enrich the 
repertoire of the ubiquitin ligases. Ubiquitin-mediated degradation has been shown to be 
important in two phases of the ce11 cycle: G 1 to S phase transition and mitosis, which 
includes metaphase to anaphase transition and mitotic exit (King et al. 1996). 
Biochemical reconstitution of the ubiquitination of Sic 1 protein defined a modular 
ubiquitin-protein ligase complex ca11ed SCF (for Skp1, Cdc53/cullin, F-box protein) 
(Feldman et al. 1997; Skowyra et al. 1997). The SCF ubiquitin ligase represents a 
conserved family of ubiquitin ligases that consist of at least four subunits (see details in 
the next section). Ubiquitination and degradation of mitotic cyclins using fractionated 
frog or clam egg extracts identified a 1000-1500 kDa ubiquitin ligase complex known as 
the cyclosome (Sudakin et al. 1995) or the anaphase-promoting complex (APC) (King et 
al. 1995). APC plays a key role in controlling the separation of sister chromatids and the 
exit from mitosis by promoting the degradation of the anaphase inhibitor Pdsl and cyclin 
B (King et al. 1996). The mechanism of how APC catalyzes the ubiquitination of mitotic 
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substrates is unclear. Although APC acts like an E3 in a reaction containing E1 and E2, 
none of the APC subunits identified share sequence homology to either of the two well-
characterized E3 enzymes Ubr1 and E6-AP. Ubiquitin thioester intermediates were not 
detected with APC (King et al. 1995), suggesting that APC may facilitate the ubiquitin 
transfer of the E2 onto the substrate by binding to them. Interestingly, the Apc2 subunit 
of APC complex bears homology to the carboxyl-terminal half of Cdc53/cullin (Yu et al. 
1998; Zachariae et al. 1998), raising the possibility that APC and SCF ubiquitin ligases 
share a common enzymatic mechanism. 
The 26S proteasome 
The physical destruction of multiubiquitinated proteins is carried out by a 2.5 
MDa, A TP-dependent protease complex called the 26S proteasome (Voges et al. 1999). 
It is composed of more than 30 subunits, which assemble into two distinct subcomplexes: 
a central barrel-shaped proteolytic core called 20S proteasome and one or two flanking 
regulatory particles called the 19S caps. Bacterial and eukaryotic 20S proteasomes look 
very similar in structure. They are all arranged as a stack of four rings, each containing 
six or seven subunits. High-resolution crystal structure of the budding yeast 20S 
proteasome suggests slightly more complexity in organization of the eukaryotic subunits 
(Groll et al. 1997). The inner surface of the 20S core contains strong hydrolytic activities 
that processively attack the peptide bonds of the trapped proteins, releasing short oligo-
peptides as end products. The functional organization of the 1 9S cap is still not very well 
characterized because few subunits have been shown to have specific functions. 
Structurally, the 19S cap can be further divided into two components: a base complex, 
which is proximal to the 20S core, and a distal lid complex (Glickman et al. 1998). The 
base complex contains six ATPases that appear to assemble into a six-membered ring that 
forms the interface between the 19S cap and the 20S core. Functions of these A TPases 
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are not entirely clear. Crystal structure of the yeast 20S core indicates that the ends of the 
cylinder are closed (Groll et al. 1997). It is been proposed recently that the A TPases in 
the base of the 19S cap may be involved in the gating of the proteolytic channel within 
the 20S core (Larsen and Finley 1997). If the multiubiquitin chains target proteins for 
degradation by the 26S proteasome, it is conceivable that there should be components in 
the proteasome that recognize and bind the multiubiquitin chains. A 50kDa subunit 
called S5a of the 26S proteasome from human erythrocytes was first found to bind K48-
linked ubiquitin chains (Deveraux et al. 1994 ). The yeast homolog is Rpn 10 subunit of 
the 19S regulatory particle. Deletion of RPN 10 in yeast does not result in a dramatic 
phenotype (van Nocker et al. 1996), suggesting that Rpn 10 may not be the only 
recognition component for ubiquitin conjugates within the 19S complex. Recent 
evidence indicates that a tetra-ubiquitin chain serves as the minimal targeting signal for 
degradation (Thrower et al. 2000). A one-step affinity purification scheme of yeast 26S 
proteasome was developed recently (Verma et al. 2000), and in vitro degradation assays 
demonstrate that the purified proteasome is sufficient to rapidly degrade multi-
ubiquitinated Sic I protein (R. Verma, personal communication). 
The SCF ubiguitin ligases 
G 1- S transition and Sicl 
Cells divide to pass genetic information from one generation to the next. This is 
achieved through a series of ordered events that make up the so called cell division cycle. 
The classical eukaryotic cell cycle consists of four phases: G 1, S, G2, and M. During this 
period, two important goals are accomplished. First, DNA is accurately duplicated once 
and only once in the S phase. Second, the replicated chromosomes are faithfully 
segregated into the daughter cells in M phase (mitosis). The gap phases that occur before 
(G 1) and after (G2) S phase are also tightly regulated to insure the normal progression of 
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the cell cycle. In G 1 phase, cells continue to grow in size if the nutrient or growth factors 
are available. Meanwhile, molecular events take place inside the ce11s to prepare them 
for the next phase, DNA replication. When cells reach a point called Start in budding 
yeast, or Restriction Point in animal ce11s, they become committed to a new round of cell 
division. Once a cell has passed Start or Restriction Point, it will divide regardless of the 
nutrient conditions. 
Classical cell cycle studies identified the molecular driving force of the cell 
cycle: a family of protein kinases known as the cyclin-dependent kinases (CDKs) 
(Murray and Hunt 1993). The activities of these kinases are modulated in part by their 
cyclin partners, which are unstable proteins whose expressions and levels change at 
different stages of the ce11 cycle. Cell cycle progression is dependent upon the activation 
and inactivation of specific CDKs. In budding yeast, the cell cycle is controlled by a 
single CDK ca11ed Cdc28, which can associate with specific cyclins at different stages of 
the cell cycle to form functionally distinct CDK complexes. Three partially redundant 
G 1 cyclins, Cln 1, Cln2, and Cln3 form G 1 cyclin-CDKs that control events unique to G 1 
phase. Six B-type cyclins (Clbs) form Clb-Cdc28 CDK complexes that drive later 
events. Specifically, S-phase cyclins Clb5 and Clb6 are activated in late G 1 to promoteS 
phase entry, and Clbl-4 are activated later to control the G2 and M phase events. 
At Start, cells have high activities of Cln/Cdc28, and inactive Clb/Cdc28. At G 1 
to S phase transition, S phase-inducing Clb5/Cdc28 and Clb6/Cdc28 complexes are 
activated. These Clb/Cdc28 kinases play important roles in DNA replication (Epstein 
and Cross 1992; Schwob and Nasmyth 1993). 
How areS-phase cycl in-CDKs activated? Genetic studies have identified genes 
that are required for G 1 IS phase transition, including CDC34 (Schwob et al. 1994 ), 
CDC4 (Hereford and Hartwell 1974), CDC53 (Mathias et al. 1996), and SKP 1 (Bai et al. 
1996). These genes are essential, and cells carrying temperature-sensitive alleles of these 
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genes arrest at late G 1 with large multi budded morphology and unreplicated DNA. Also, 
G 1 cyclins are required for cells to traverse Start (Nasmyth 1993). The finding that 
Cdc34 is a ubiquitin-conjugating enzyme (Goebl et al. 1988) hinted at a link between the 
G 1/S transition and ubiquitin-mediated proteolysis. The break-through came when 
elegant work from Nasmyth's laboratory revealed that cdc34 mutants can not enterS 
phase because they fail to degrade the Sic 1. Sic 1 was identified as a 40 kDa protein that 
binds tightly to Cdc28 protein and inhibits its activity (Mendenhall 1993; Nugroho and 
Mendenhall 1994 ). It was also identified as a high copy suppressor of temperature-
sensitive dbf2 mutants that exhibit a mitotic arrest phenotype (Donovan et al. 1994). 
Work from Schwob et al. (1994) shows that Sicl protein appears at the end of mitosis 
and disappears shortly before S phase, and it is a potent inhibitor of Clb, but not Cln 
forms of the Cdc28 kinase. Their results also indicate that Clb5/Cdc28 activity peaks 
around S phase and B-type cyclins are required for DNA replication. Taken together, 
these observations led to the hypothesis that Cdc34 promotes the ubiquitination of Sic 1 
and subsequent destruction, which is required for activation of B-type cyclin/CDKs and 
entry into S phase. Consistent with this, deletion of S/Cl gene alleviates the inhibition of 
DNA replication in cdc341' , cdc4", cdc53/J, and skpl" mutants at restrictive temperature 
(Schwob et al. 1994; Bai et al. 1996), and rescues the inviability of clnl cln2 cln3 triple 
deletion mutant (Schneider et al. 1996; Tyers 1996). On the other hand, overexpression 
of a non-degradable Sic I would block cell cycle transition at the Gl/S boundary (Verma 
et al. 1997a). 
Identification of the prototype SCF complex 
Genetic analyses have implicated a role for CDC4, CDC53, and SKPJ gene 
products at the G 1/S transition. However, the sequences of these proteins do not shed 
much light on their functions. There is no sequence homology between any of these gene 
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products and the well-known E3 proteins, such as Ubrl and E6-AP. Interestingly, 
CDC34, CDC4, CDC53, and SKP 1 interact genetically and physically. Pair-wise double 
mutants of cdc34, cdc4, and cdc53 exhibit a synthetic lethal phenotype, and mutations in 
CDC4 and CDC34 can be suppressed by overexpression of CDC53 (Mathias et al. 1996). 
SKP 1 was identified as a suppressor of cdc41" mutant, and Skp 1 protein binds tightly to 
Cdc4 directly through a motif in Cdc4 called the"F-box" (Bai et al. 1996). Taken 
together with the evidence that Cdc34, Cdc53, and Cdc4 co-purify in vivo (Mathias et al. 
1996), it is likely that these four proteins are part of a protein complex that act in concert 
to promote G 1/S transition in budding yeast. 
Since Cdc34 is a ubiquitin-conjugating enzyme, it appeared attractive that 
components of the Cdc53, Cdc4, and Skpl may serve as the ubiquitin ligase. To test this 
possibility, Deshaies laboratory set up an in vitro assay system to study the ubiquitination 
of Sic I (Verma et al. 1997b ). This system was based on fractionated yeast extracts as 
first described in Deshaies et al. ( 1995). In vitro analysis first identified Cdc34 and Cdc4 
as necessary components for Sic1 ubiquitination (Verma et al. 1997c). F inally, purified 
Cdc34, Cdc4, Cdc53 and Skp 1 were demonstrated to be sufficient to catalyze the 
ubiquitination of phosphorylated Sic 1 in vitro (Feldman et al. 1997; Skowyra et al. 1997). 
The trimeric protein complex _S_kp1/Cdc53/Cdc4 (F-box protein) was named as SCF. 
Since it qualifies as an E3 according to classical definition, SCF complex appeared to be 
a novel family of ubiquitin ligases. I will now refer to the ubiquitination pathway defined 
by Cdc34/SCF as the "SCF pathway." 
Identification of a new SCF subunit 
Recent work from several labs identified a fourth subunit of SCF, referred as 
Roc 1 /Rbx 1 in mammals, or Hrt1 in budding yeast (Kamura et al. 1999; Ohta et al. 1999; 
Seol e t al. 1999; Tan et al. 1999). Hrt I was purified from Skp 1 and Cdc53 
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immunoprecipitates and identified by mass spectrometry (Seol et al. 1999). HRTJ is 
essential, and hrtl'-' cells arrest at G1/S transition. Sic1 and G1 cyclin Cln2 are stabilized 
in hrtl" cells. Biochemical studies indicates that Hrt1 is important for SCF function 
because recombinant Hrt1 assembles into recombinant SCF complexes and potently 
stimulates in vitro ubiquitination reactions (Seol et al. 1999). Moreover, using Cdc34 
autoubiquitination (Banerjee et al. 1993) as an assay, in vitro evidence suggests that 
Cdc53 and Hrt1 comprise a ubiquitin ligase module within the tetrameric SCF complex 
(Seol et al. 1999). Interestingly, Roc1/Rbx 1/Hrt1 is homologous to the Ape 11 subunit of 
the APC (Zachariae et al. 1998) in that they share a highly conserved zinc-binding RING-
H2 domain. Similarly, the ubiquitin ligases (Ubr1 and E3a) involved inN-end rule also 
contain a putative RING finger (Kwon et al. 1998). Taken together, SCF and Ubrl may 
represent divergent families of RING finger-based ubiquitin ligases. Furthermore, other 
RING finger proteins, such as SINA (Hu and Fearon 1999), Der3/Hrdl (Bordallo et al. 
1998), Mdm2 (Honda et al. 1997), and Radl8 (Bailly et al. 1997) could also be potential 
ubiquitin ligases and therefore increase the repertoire of this E3 family. Two recent 
examples of the RING finger type ubiquitin ligases are the tyrosine kinase negative 
regulator c-Cbl (Joazeiro et al. 1999) and lAPs (inhibitor of _m:!optosis) (Yang et al. 2000). 
Architecture and Conservation of SCF complexes 
The Skpl binding site within Cdc4 is a degenerate 40 amino acid motif called F-
box, after human cyclin F (Bai et al. 1994). Work done in parallel to that of Sicl has 
found that Cdc34, Cdc53, and Grr1 are required for the degradation of G 1 cyclins (Barral 
et al. 1995; Deshaies et al. 1995; Willems et al. 1996). G 1 cyclins are inherently 
unstable, and their instability is critical for the proper regulation of cell cycle progression. 
Grr1 is required for glucose repression in budding yeast (Flick and Johnston 1991 ). 
Sequence analysis shows that Grrl also carries an F-box motif. Some conditional alleles 
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of skpl result in stabilization of Cln2 (Bai et al. 1996), suggesting that Skp 1 is also 
required for G 1 cyclin degradation. Sic 1 and Cln2 degradation pathways appeared to 
share the same core components (Cdc53, Cdc34, and Skp 1 ), but differ in the F-box 
protein (Cdc4 versus Grr1 ). Database search in budding yeast genome has identified 17 
proteins that carry an obvious F-box motif (Patton et al. 1998b), and at least three (Cdc4, 
Grr1, and Met30) have been shown to assemble into functional complexes in vivo (Patton 
et al. 1998a). It is proposed that multiple SCF complexes exist in vivo, and they differ in 
the F-box proteins, which recruit specific substrates to Skp 1 and the ubiquitination 
machinery (Bai et al. 1996). This idea is referred to as the "F-box hypothesis". Distinct 
SCF complexes are often designated by their F-box receptors (e.g. scpCdc4, SCF Grri, and 
SCFMe130) . Besides G1 cyclins, Gic2, a protein involved in actin polarization at bud 
emergence (Brown et al. 1997), has been shown to be targeted for degradation by the 
SCF Grri complex (Jaquenoud et al. 1998). MET30 is an essential gene involved in sulfur 
amino acid metabolism (Thomas et al. 1995). SCFMc'30 complex have been implicated in 
promoting the degradation of the CDK-inhibitory kinase Swel (Kaiser et al. 1998) and 
transcription activator Met4 (Rouillon et al. 2000). Recent evidence, however, suggest 
that SCFMc130-dependent ubiquitination of Met4 may not lead to its proteolysis (Kaiser et 
al. 2000). 
F-box proteins are found in higher organisms as well, suggesting that SCF 
functions are conserved. Examples are Skp2 (Zhang et al. 1995; Marti et al. 1999), 13-
TrCP (Margottin et al. 1998), and NFB42 (Erhardt et al. 1998) in humans. SEL-10 in C. 
elegans (Hubbard et al. 1997), slimb in Drosophila (Jiang and Struhl 1998), and UFO in 
A. thaliana (Lee et al. 1997). 
Skp1 is a small (163 amino acid) and highly conserved protein that serves as a 
linker in SCF complexes by binding to both the F-box receptor proteins and the 
Cdc53/Hrtl ubiquitin ligase modules. Interesting, Skp 1 has been also been found to be 
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part of other complexes that are distinct from SCF. These include the centromere binding 
protein complex CBF3 (Connelly and Hieter 1996) and RAVE, a regulator of V-A TPase 
assembly (Seol et al. 2001). A human Skpi-like molecule Elongin Cis part of the VHL 
(von Hippel-Lindau) complex involved in transcription elongation (Lonergan et al. I 998). 
Cdc53 is a large protein (8 I 4 amino acids) whose function has been most elusive. 
It was proposed that Cdc53 serves as a scaffold protein for multiple Cdc34/Skpl/F-box 
protein complexes (Patton et al. I 998a). However, recent evidence suggests that Cdc53, 
together with Hrti, acts as a RING-H2 based ubiquitin ligase module that activates 
ubiquitin transfer from Cdc34 to substrates (Seol et al. I 999). The counterparts of Cdc53 
in higher organisms includes Cul-l in C. elegans (Kipreos et al. I 996) and Cull-5 in 
humans (Deshaies I 999). SCF is therefore sometimes referred to as Skp I/Cullin/F-box 
protein. 
Hrtl, despite being the smallest subunit of SCF so far, appears to bind Cdc53, the 
F-box proteins Grri and Cdc4, and also in a direct way to the E2 Cdc34 (Kamura et al. 
I 999; Seol et al. I 999; Skowyra et al. 1999). The mechanism behind the stimulatory 
effect of Hrti in SCF-dependent ubiquitination reactions is not clear, but may have 
something to do with its interaction with the E2 enzyme. 
It is noteworthy that although existing evidence suggests that in budding yeast 
Cdc34 is the primary E2 that forms ubiquitination machinery with SCF complexes, there 
may be other E2-SCF combinations. The human SCF appears to collaborate with hUBC5 
in ubiquitinating IKBa (Yaron et al. 1998; Spencer et al. 1999). 
The role of substrate phosphorylation 
The link between substrate phosphorylation and ubiquitin-dependent degradat ion 
via SCF pathway (referred to earlier as Cdc34 pathway) was first suggested by the 
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observations that degradation of G 1 cyclins and the Cdc34-dependent ubiquitination of 
Cln2 in vitro requires Cdc28 activity (Deshaies et al. 1995; Yaglom et al. I995). 
More evidence came from studies of the CDK inhibitor Sic I, which is stable in 
early G 1 cells but is abruptly degraded at the G 1-S transition. What primes Sicl 's 
destruction? Genetic studies indicate that C1n/Cdc28 kinase activity is required for Sicl 
degradation because Sicl is accumulated in cdc28 mutants and CLN-depleted ce1ls 
(Schwob et al. 1994; Schneider et al. 1996). What is the exact role of C1n/Cdc28 in Sic 1 
turnover? In vitro ubiquitination studies of Sic 1 provided biochemical evidence that 
phosphorylation of Sic 1 by Cln/Cdc28 is required for the multi-ubiquitination of Sicl 
(Verma et al. 1997c). Once Sicl is phosphorylated, it can be ubiquitinated in a Cdc34-
dependent manner in the absence of Cln2/Cdc28 activity (Verma et al. 1997c). Mutation 
of critical CDK phosphorylation sites in Sic1 not only dramatically reduces Sicl 
ubiquitination in vitro but also stabilizes it in vivo (Verma et al. 1997a). Taken together, 
these results suggest that phosphorylation of Sic 1 by C1n/Cdc28 is both necessary and 
sufficient to trigger its ubiquitination and subsequent degradation. 
Why does Sicl have to be phosphorylated in order to be ubiquitinated by 
Cdc34/SCF? The answer came when Sic I ubiquitination was reconstituted in vitro using 
a defined set of purified protein components. Phosphorylation of Sic 1 is necessary for 
recognition by the SCF complex, specifically by the F-box protein Cdc4 because Cdc4 
binds only to phosphorylated, but not unphosphorylated, Sic I (Feldman et al. 1997; 
Skowyra et al. 1997). Similarly, phosphorylation of Cln2 by Cdc28 kinase, its cognate 
CDK subunit, is required for its rapid turnover in vivo (Lanker et al. 1996). Grr 1 binds 
selectively to phosphorylated Cln 1 and Cln2 (Skowyra et al. 1997). Reconstitution of 
Cln2 using purified scpGrrl was made possible after the discovery of Hrt1 (Seol et al. 
1999; Skowyra et al. 1999). It appears that substrate phosphorylation serves as a signal 
for the recognition and binding of the SCF complexes. 
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Besides Sic 1 and G I cyclins, phosphorylation by Cdc28 kinase is also required 
for the rapid turnover of CDK inhibitor Far] (Henchoz et al. 1997) and replication 
initiation factor Cdc6 (Elsasser et al. 1999). Whereas Cln2/Cdc28 promotes the 
ubiquitination of Far I in vitro, Clb5/Cdc28 is the preferential kinase that promotes the 
ubiquitination of Cdc6. In vitro assays using fractionated yeast extracts also show that 
Cdc34-dependent ubiquitination of Farl and Cdc6 also requires Cdc4, the F-box subunit 
of SCFcctc4 (see Chapter 2). Farl and Cdc6 turnover have been shown to be dependent on 
scpCctc4 (Drury et al. 1997; Henchoz et al. 1997). Gcn4, a transcription factor involved in 
general control of amino acid biosynthesis, is also degraded in a SCFcdc4-dependent 
manner in vivo (Meimoun et al. 2000), and is ubiquitinated by scpectc4 in vitro (see 
Chapter 3). Gcn4 degradation in vivo and ubiquitination in vitro also require CDK 
phosphorylation. Interestingly, Cdc28 is not required. Instead, Pho85 CDK, a kinase 
involved in phosphate metabolism, has been implicated to be required for Gcn4 turnover 
(Meimoun et al. 2000). Biochemical studies of Gcn4 ubiquitination in vitro also 
identified Srb 10 CDK, a component of the RNA polymerase II holoenzyme, as a potent 
kinase that phosphorylates Gcn4 and promotes Gcn4 turnover by the SCFcctc4 pathway. 
Mutation of CDK phosphorylation sites on Gcn4 greatly stabilizes Gcn4. Our work and 
the work from Meimoun et al . 2000 suggest that more than one kinase may be needed to 
insure the rapid turnover of key regulatory proteins. Similarly, Pho85 CDK has been 
implicated to promote Sic I degradation in addition to Cdc28 CDK (Nishizawa et al. 
1998). 
So far, substrate phosphorylation (by a CDK) appears to be a common theme for 
SCF recognition and targeting, at least for scpCctc4 • Whether it is applicable all scpCctc4 
substrates or to SCF complexes containing other F-box proteins remains to be seen. One 
indication that substrate phosphorylation may be a conserved feature for SCF targeting 
came from in vitro reconstitution of IKBa ubiquitination. The human F-box protein (3-
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TrCP (E3RS) binds specifically to phosphorylated IKBa to promote its ubiquitination by 
SCF B-TrCP (Yaron et al. 1998; Spencer et al. 1999; Winston et al. 1999). 
It is still unclear how F-box receptors bind phosphorylated substrates. One 
possibility is that they directly bind to the phosphate epitopes. The other possibility is 
that they bind to other regions of the substrate molecule. The former possibility is 
supported by the evidence that a short IKBa phosphopeptide can compete with full length 
IKBa for binding to 13-TrCP (Yaron et al. 1998). 
Ubiguitin-dependent degradation of transcription factors 
Besides the cell cycle regulators discussed above, many transcription factors are 
also regulated by ubiquitin-dependent degradation. The intracellular levels of proteins 
are often controlled at the transcriptional level, which critically depends on the rate of 
transcriptional initiation. It is conceivable that precise modulation of the levels of 
specific transcripts therefore requires tight regulation of the transcription factors. The 
rapid and irreversible features of the ubiquitin-dependent degradation make it an 
attractive means of transcriptional regulation. A few yeast transcription factors are 
known to have very short half-lives (3-5 min). These include Mata2 (Hochstrasser and 
Varshavsky 1990) and Gcn4 (Kornitzer et al. 1994). The mammalian transcription 
factors c-Fos (Curran et al. 1984) and c-myc (Luscher and Eisenman 1988) have half-
lives of about 20 min. So far, most short-lived transcription factors are degraded through 
the ubiquitin-proteasome pathway. Several examples will be discussed below with the 
emphasis on the yeast transcription activator Gcn4. My work (see Chapter 3) and work 
from Meimoun et al. (2000) demonstrate that Cdc34/SCP:dc4 pathway ubiquitinates Gcn4 
and targets it to rapid degradation in vivo. 
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Introduction to Gcn4 
Gcn4 is a well-studied yeast transcription activator involved in the activation of 
amino acid and purine biosynthetic genes (Hinnebusch 1992). Yeast cells have 
developed a complex system to regulate the amino acid biosynthetic genes. The 
expression of at least 35 genes encoding enzymes in 12 different amino acid biosynthetic 
pathways is co-regulated such that when cells are starved for any one of a different 
number of amino acids, the expression of many genes from different pathways is 
derepressed. This cross-pathway regulation is referred to as the "general amino acid 
control" (Delforge et al. 1975). Genetic studies of general amino acid control have 
identified positive and negative regulators. GCN (general control non-derepressible) 
genes are positive regulators. Among these, GCN4 is the most proximal positive effector 
of gene expression. Besides amino acids, Gcn4 has also been found to regulate a gene 
involved in purine biosynthesis (Mosch et al. 1991). 
Gcn4 has 281 amino acids which harbor two functional domains. The 
transcriptional activation domain was original thought to be located in a 19 acidic amino 
acid stretch central in the molecule (Hope and Struhl 1986). However, recent evidence 
suggest that multiple hydrophobic regions of Gcn4 contribute redundantly to Gcn4's 
transcriptional activation function (Drysdale et al. 1995; Jackson et al. 1996). The DNA 
binding domain is a 60 amino acid stretch that forms a basic leucine zipper. The basic 
region of Gcn4 makes contact with DNA, and mutations in the conserved residues 
abolishes Gcn4 DNA-binding in vitro and activity in vivo (Pu and Struhl 1991 ). The 
leucine zipper is required for Gcn4 dimerization, and the crystal structure of a C-terminal 
peptide indicates that Gcn4 leucine zipper is a classical parallel coiled-coil (O'Shea et al. 
1991 ). Crystal structure of the protein-DNA complex shows that Gcn4 basic region binds 
DNA as a dimer (Ellenberger et al. 1992). Gcn4 synthesized in vitro binds to H/53 
regulatory sequences, providing the first evidence that Gcn4 is a DNA-binding 
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transcription factor (Hope and Struhl 1985). The C-terminal 60 amino acids of Gcn4 are 
sufficient to form a homodimer that binds target DNA. Furthermore, the stable Gcn4 
dimers can be formed in the absence of DNA (Hope and Struhl 1987). 
Mutational analyses of a few amino acid biosynthesis genes, including HIS3, 
HIS4, TRP4, and TRP5 have established that a short nucleotide sequence located 
upstream of the start sites of these genes mediates their transcriptional activation by Gcn4 
in response to amino acid starvation. This sequence, about 12 base pairs long with a 
highly conserved hexanucleotide core TGACTC, has been shown to be the binding site 
for Gcn4 (Hope and Struhl 1985; Arndt and Fink 1986). The completion of the yeast 
genome project allows the potential characterization of a full spectrum of Gcn4 target 
genes. A recent computer search program using the Gcn4 binding site element has found 
that about 1% of the genes in the yeast genome carry three or more Gcn4-binding sites in 
their promoter region (Schuldiner et al. 1998). More than 50% of these genes are 
involved in amino acid and nucleotide metabolism. Other potential targets of Gcn4 
include genes involved in transcription and cell growth. 
How is Gcn4 regulated? Studies from Hinnebusch and workers in the 1980s have 
shown the Gcn4 expression is regulated mainly at the translational level. The 5 ' leader of 
GCN4 mRNA contains four small uORFs (upstream open reading frames). These uORFs 
are essential for repression of GCN4 to restrict the flow of scanning ribosomes to reach 
the GCN4 start codon when amino acids are abundant. However, the 5' proximal AUG 
condons play a positive role in GCN4 expression under amino acid starvation conditions 
(Mueller and Hinnebusch 1986). A deletion of all four uORFs results in high constitutive 
GCN4 expression independent of factors that normally regulate its expression 
(Hinnebusch 1984; Thireos et al. 1984 ), consistent with their role in translational control 
of GCN4. Most yeast genes do not have even a single uORF, and insertion of a uORF in 
the mRNA leader of a gene invariably reduces the translation of the downstream genes. 
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These observations suggest that the eukaryotic ribosome scanning model for translation 
initiation (Kozak 1978) also operates in yeast. What is the molecular mechanism 
governing the translational control of GCN4 expression by uORFs? The identification of 
Gcn2 as a protein kinase involved in GCN4 translation provided the first clue (Roussou et 
al. 1988; Wek et al. 1990). Shortly after, it was found that Gcn2 phosphorylates the a 
subunit of the eukaryotic translation initiation factor2 (eiF-2a) and thereby activates 
GCN4 translation under amino acid starvation conditions (Dever et al. 1992). 
The C-terminal sequence of Gcn4 is similar to that of mammalian AP-I 
transcription factors. Gcn4 shares 44% and 28% identities with the Jun and Fos proteins 
respectively over the 70 C-terminal residues of Gcn4 (Vogt et al. 1987). Mammalian AP-
I transcription factors have been shown to regulate the UV response, which also involves 
the Ras signaling pathway (Karin 1998). Interestingly, UV irradiation of yeast leads to 
increased translation of Gcn4 mRNA in a Gcn2-independent manner and a post-
translational event (Engelberg et al. 1994), suggesting a conservation of UV response 
pathway between yeast and mammals. Recently, it has been shown that RPNJJ , a gene 
encoding a regulatory subunit of the 26S proteasome, is required for the activation of 
GCN4 target genes through an amino acid starvation-independent pathway (Stitzel et al. 
2001). 
Ubiquitin-dependent degradation of Gcn4 
Although Gcn4 is one of the best-studied transcription factors in yeast, most of 
the work in the past two decades has been focused on its structure and translational 
control. Very little attention has been given to the post-translational control mechanisms 
of Gcn4. One study by Kornitzer et al. (1994) provided the first indication that Gcn4 
may be regulated tightly by post-translational mechanisms such as ubiquitin-mediated 
degradation. In this work, they show that Gcn4 is a short-lived protein with a half-life of 
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5 min or less. The reason why Gcn4 is short lived is not clear. Strong overexpression of 
Gcn4 (e.g. under the GAL promoter) significantly slows cell growth (my unpublished 
observations), suggesting a toxic effect possibly due to wasteful biosynthesis of unneeded 
compounds, or a "squelching" effect (Gill and Ptashne 1988) on the transcription 
machinery. There may be cis-acting sequences that make Gcn4 inherently unstable. A 
recent study on the stability of artificially constructed transcription activators shows that 
the rate of degradation of activators correlates with their activation domain potency 
(Molinari et al. 1999). By this model, Gcn4 may be a potent activator and therefore gets 
degraded rapidly. In any event, it is clear that the intracellular concentration of Gcn4 is 
tightly regulated. 
In the report by Kornitzer et al. ( 1994 ), Gcn4 was found to be ubiquitinated in 
vivo, and a mutant in the proteasomal regulatory subunit Cim5 inhibits Gcn4 degradation, 
indicating that Gcn4 is degraded by the ubiquitin-proteasome pathway. Consistent with 
this, they also found that Gcn4 is stabilized in a cdc34 or rad6t1 mutant, suggesting that 
Cdc34 or Rad6 ubiquitin conjugating enzymes may be directly involved in ubiquitinating 
Gcn4. Although Rad6 is sufficient to ubiquitinate Gcn4 in fractionated yeast extracts 
(my unpublished observations), this Rad6-dependent ubiquitination pathway is not yet 
characterized. A novel ubiquitin ligase may associate with Rad6 in this reaction because 
UBRJ is not required for rapid turnover of Gcn4 (Kornitzer et al. 1994 ). Moreover, the 
physiological role of the Rad6 in Gcn4 turnover is not clear. It appears, however, that the 
Rad6-dependent degradation of Gcn4 contributes less than the Cdc34 pathway in vivo 
(see Chapter 3). The finding of Cdc34-dependent degradation of Gcn4 is particularly 
interesting because the known Cdc34 substrates (G 1 cyclins, Cdc6, Farl, and Sicl) are all 
cell cycle regulators. Study of the mechanism and regulation of Gcn4 ubiquitination 
provides a different angle in addressing the generality of the Cdc34-dependent (later 
known as SCF) ubiquitination pathway. 
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My thesis work (detailed in Chapter 3) started with the attempt to identify factors 
necessary for Gcn4 ubiquitination in vitro, and it paralleled with the effort to reconstitute 
Sic I ubiquitination. Through biochemical purification and an educated guess, I identified 
SrblO as a kinase that phosphorylates Gcn4 and promotes its ubiquitination in vitro. 
With the identification of SCF, I was able to reconstitute Cdc34/SCP:dc4-dependent Gcn4 
ubiquitination using fully purified protein components. SrblO/Srbll is a cyclin/CDK 
pair that associates with the RNA polymerase II holoenzyme (Liao et al. 1995). Gcn4 is 
phosphorylated in vivo in SrblO-dependent manner and is partially stabilized in srbJO 
mutants, indicating that Srb 10 CDK contribute to the rapid degradation of Gcn4 in vivo. 
Furthermore, mutations of CDK phosphorylation sites on GCN4 significantly stabilize 
the protein, demonstrating that degradation is mediated through CDK phosphorylation. 
Parallel to my work, Kornitzer and co-workers provided genetic evidence that 
Gcn4 is degraded in an SCP:dc4-dependent manner in vivo (Meimoun et al. 2000). 
Interestingly, they found that Pho85 is required for the rapid degradation of Gcn4. Pho85 
is a CDK involved in phosphate assimilation and glycogen synthesis (Kaffman et al. 
1994; Huang et al. 1998). However, Gcn4 is only partially stabilized in a pho85 11 
mutant. My subsequent work shows that Gcn4 is nearly completely stabilized in a 
srb1011 pho8511 double mutant, suggesting SrblO and Pho85 contribute redundantly to 
Gcn4 turnover in vivo. Taken together, these results indicate that the mechanisms of 
ubiquitination of Gcn4 and Sic 1 differ in two ways. First, the kinase that targets their 
ubiquitination is different: Sic 1 utilized G 1 cyclin-CDK whereas Gcn4 utilizes Srb 10 and 
Pho85 CDKs. Second, whereas Cdc28 is likely to be the only physiological kinase that 
targets Sicl degradation, two different CDKs are required to promote rapid Gcn4 
degradation in vivo. Differential targeting by substrate specific kinases therefore may not 
only allow a single SCF pathway to simultaneously control multiple cellular processes 
but also make these kinases attractive targets for regulation in the degradation pathway. 
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If both Srb 10 and Pho85 CDKs target Gcn4 for SCF-dependent degradation, then 
what are the roles of each of the kinases? Gcn4 turnover appears to be constitutive when 
cells are grown in rich medium. However, it is stabilized upon amino acid starvation 
(Kornitzer et al. 1994). A recent report by Meimoun et al. (2000) shows that Gcn4 is 
stabilized through the down regulation of Pho85 and the loss of phosphorylation of Gcn4 
at T165, which appears to be necessary for rapid Gcn4 turnover. This suggests that the 
Pho85-dependent degradation pathway is responsive to amino acid starvation signals. In 
contrast, our studies show that Srb 1 0-dependent phosphorylation of Gcn4 is largely 
intact, and loss of Srb 10 further stabilizes Gcn4 even under starvation conditions. This 
suggests that Srb 1 0-dependent phosphorylation and degradation of Gcn4 are not 
regulated through amino acid starvation, and may represent a constitute pathway that 
promotes Gcn4 turnover. Srb10 CDK is part of the RNA polymerase II holoenzyme, 
which is recruited to the vicinity of the promoters of target genes during activated 
transcription. It has been shown that Gcn4 interacts with the RNA polymerase 
holoenzyme components at least in vitro (Drysdale et al. 1998; Natarajan et al. 1999). It 
therefore seems plausible that the role of Srb 1 0-dependent phosphorylation and 
degradation of Gcn4 is to limit its duration at the promoters. Pho85 is a nuclear CDK and 
there has been no reports suggesting that it may be localized to DNA. Multiple cyclins 
form CDK complexes with Pho85 in vivo (Andrews and Measday 1998). The Pho85 
CDK formed by the cyclin Pc11 has been shown to phosphorylate Gcn4 in vitro 
(Meimoun et al. 2000). However, there is no evidence that phosphorylation of Gcn4 by 
Pcll /Pho85 is sufficient to promote SCF-dependent ubiquitination in vitro. Furthermore, 
Gcn4 is not stabilized in a pcll L1 mutant or several other Pho85 associated cyclin mutants 
(Meimoun et al. 2000), suggesting the multiple Pho85 CDK may redundantly contribute 
to Gcn4 turnover in vivo. 
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Our recent preliminary results (see Chapter 4) show that a DNA-binding mutant 
of Gcn4 is significantly stabilized in vivo with a half-life of about 30 min, ten-fold longer 
than that of the wild-type Gcn4. This raises the intriguing possibility that only promoter-
bound Gcn4 molecules are subjected to the negative regulation by degradation, and 
phosphorylation of Gcn4 may be confined to the vicinity of the promoter DNA of target 
genes. Interestingly, this DNA-binding mutant of Gcn4 is not further stabilized to an 
appreciable extent in an srbl 011 or a pho8511 mutant, suggesting both CDKs target 
promoter-bound Gcn4. The exact role of each CDK is still not clear at this moment. 
Conceivably, they may target different pools of Gcn4 molecules or respond to different 
cellular signals. 
Ubiquitin-dependent degradation of other transcription factors 
Met4 
Met4 is a basic leucine zipper transcription factor similar to Gcn4. It is the major 
transcription activator of many genes involved in sulfur amino acid metabolism (Thomas 
and Surdin-Kerjan 1997). It was reported that the stability of Met4 depends on the 
concentrations of extracellular methionine. At repressive concentrations, Met4 has a 
short half-life ( < 10 min), and its degradation is dependent on SCFMe130 (Rouillon et al. 
2000). However, a different report shows that Met4 is a stable molecule and the scpM•'30 
-dependent ubiquitination of Met4 does not promote its turnover. Instead, this 
modification appears to directly inactivate Met4 (Kaiser et al. 2000). Kaiser et al. (2000) 
shows that Met4 is ubiquitinated in vivo, and the F-box protein Met30 binds to Met4 and 
is required for Met4 ubiquitination in vitro. Furthermore, Met4 ubiquitination in vivo 
appears to result in the attachment of short ubiquitin chains. Although this report reveals 
a potential proteolysis-independent function for Cdc34/SCF, it remains to be seen 
whether this novel function is general. 
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Mata2 
The mating type (MAD locus of budding yeast encodes transcription regulators 
that determine the cell type. Mata2 is a transcription repressor of a cell-specific genes in 
a cells or a/a cells. It is a short-lived protein (Hochstrasser and Varshavsky 1990), and 
the ubiquitin-dependence of Mata2 degradation was first suggested by the observation 
that Mata2 is multiubiquitinated in vivo (Hochstrasser et al. 1991). Subsequently, it was 
shown that four ubiquitin-conjugating enzymes, Ubc4, Ubc5, Ubc6, and Ubc7, are 
required for rapid degradation of Mata2 (Chen et al. 1993). These Ubc enzymes can be 
assigned to two separate ubiquitination pathways or complexes that work via distinct 
structural elements in Mata2. Ubc6 and Ubc7 can physically associate and define one of 
the pathways that target the Degl degradation signal of Mata2 (Chen et al. 1993). A 
recent report demonstrates that the degradation signal of Mata2 confers nuclear-specific 
turnover to a reporter protein (Lenk and Sommer 2000). These observations suggest that 
the half-life of a short-lived protein may be determined by the utilization of both 
combinatorial ubiquitination machinery and the compartment-specific turnover. 
c-Fos and c-Jun 
The proto-oncogene products c-Fos and c-Jun heterodimerize through their 
leucine zippers to form the AP-1 transcription factor, which is involved in cell 
proliferation following mitogenic stimuli (Angel and Karin 1991 ). Both c-Fos and c-Jun 
have relatively short half-lives (about 20 and 90 min, respectively) as opposed to their 
oncogenic counterparts v-Fos and v-Jun (Papavassiliou et al. 1992; Treier et al. 1994). 
This relative stability may account at least partly for their transforming potential. 
Degradation of c-Fos in crude reticulocyte extracts (Papavassiliou et al. 1992) or by 
purified 26S proteasome (Tsurumi et al. 1995) requires the presence of c-1 un. Tsurumi et 
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al. (1995) also shows that multiple protein kinases, including mitogen-activated protein 
kinase (MAPK) and CDC2 kinase, stimulate the degradation of c-Fos. c-Fos degradation 
is mediated by ubiquitin pathway in vivo because it is stabilized in a El mutant cell line 
(ts20), and the E2 enzymes E2-F1 or UbcH5 and a novel E3 enzyme promote c-Fos 
ubiquitination in vitro (Stancovski et al. 1995). The in vivo ubiquitination of c-Jun was 
detected first by Treier, et al. (1994). They showed that c-Jun degradation is mediated by 
the 6 domain inc-Jun. MAPK phosphorylates c-Jun on sites in the vicinity of the 6 
domain (Pulverer et al. 1991). Phosphorylation of c-Jun by MAPK has been shown to 
reduce the ubiquitination of c-Jun and increase its stability (Musti et al. 1997). In this 
respect, degradation of c-Jun is quite different from that of yeast Gcn4. 
MyoD 
MyoD is a basic helix-loop-helix (bHLH) transcription factor involved in the 
activation of genes encoding skeletal muscle-specific proteins. It has a half-life of 30-60 
min (Thayer et al. 1989; Song et al. 1998). MyoD can be ubiquitinated by E2-Fl and a 
novel E3 enzyme, E3L (Gonen et al. 1996). MyoD is degraded by the ubiqutin system in 
vivo (Abu Hatoum et al. 1998; Breitschopf et al. 1998), and its ubiquitination and 
degradation in vitro is inhibited by DNA containing MyoD binding sites (Abu Hatoum et 
al. 1998). Breitschopf et al. (1998) shows that theN-terminal residue of MyoD is 
necessary and sufficient for the ubiquitin conjugation and subsequent degradation of the 
protein. MyoD contains several consensus CDK phosphorylation sites. Song et al. 
(1998) found that S200 is required for MyoD hyperphosphorylation and degradation in 
vivo. Interestingly, they also found that the turnover of MyoD appears to require the 
cognate Cdc34 ubiquitin-conjugating enzyme. Their findings suggest a similar 
degradation mechanism for MyoD and yeast Gcn4. It remains to be seen if MyoD is 
targeted by the SCF-like ubiquitin ligase in vivo. 
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E2F-1 
E2F-1 is a cell cycle regulated transcription factor that can act as both an 
oncoprotein and tumor suppressor protein. It was shown that E2F-1 is degraded by the 
ubiquitin system (Hofmann et al. 1996; Campanero and Flemington 1997). However, the 
mechanism and regulation of this process was elusive until SCF complexes were 
identified. Marti et al. (1999) show that E2F-1 accumulates in G 1 phase, but is rapidly 
degraded in S/G2 phase, and this degradation correlates with the accumulation of SKP2, 
an F-box protein. E2F-1 interacts with CULl and SKP2 in vitro, and mutations in E2F-1 
that abolish interaction with SKP2 in vitro leads to reduced ubiquitination of E2F-1 and 
stabilizes the protein in vivo (Marti et al. 1999). These observations suggest that the 
SCF5KP2 ubiquitination pathway may promote E2F-l degradation at the S/G2 phase. 
There is no evidence that E2F-1 phosphorylation is necessary for binding to SKP2, unlike 
other interactions between substrates and F-box proteins. However, there is evidence that 
TFIIH-mediated phosphorylation of E2F-1 plays a role in triggering E2F-1 degradation 
during S phase (Vandel and Kouzarides 1999). The role of this phosphorylation event is 
unclear. Recent evidence indicates that E2Fl can be ubiquitinated in vitro by Ubc5 and 
multiple ROC-cull in ligases (Ohta and Xiong 2001 ). Furthermore, in vitro ubiquitination 
of E2F-1 by CUL I-ROC 1 ligase does not require E2F-1 phosphorylation, and the SKPI 
subunit. 
In summary, mechanism and regulation of ubiquitin-mediated degradation of 
many transcription factors are still not very clear at this moment, especially in the case of 
higher eukaryotes. It appears that distinct pathways may specify the turnover of specific 
type of transcription factors. Although the mechanism and regulation of higher 
eukaryotic transcription factors appears more complex, some features observed in yeast 
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studies are conserved for certain mammalian proteins. These include the substrate 
phosphorylation requirement for MyoD and SCF-targeting for E2F-1. 
Regulation of transcription factors by localization 
Overview 
Although ubiquitin-mediate degradation serves as an effective way of negative 
regulation of short-lived transcription activators, many of them are quite stable. Recent 
studies from several stable transcription factors indicate that transcription activators are 
also regulated at the level of nuclear transport (Komeili and O'Shea 2000). The f3-
importin family of nuclear transport receptors is responsible for the nucleocytoplasmic 
transport of most proteins. The yeast nuclear export receptors include Crm 1 (hCRMl in 
humans) and Msn5. The import receptors include Kap95 (lmportin f3 in humans) and 
Pse 1 (Ohno et al. 1998). CRM I functions in the export of proteins that carry a specific, 
leucine-rich type of nuclear export signal (NES), and Importin f3 functions in the import 
of proteins that carry a classical nuclear localization signal (NLS). An important feature 
of the nucleocytoplasmic transport is directionality. This is achieved through Ran, a 
small GTPase, and its regulators. Ran's regulators are distributed asymmetrically across 
the nuclear envelopes such that GTPase activity is favored in the cytoplasm and 
GDP/GTP exchange in the nucleus. As a result, nuclear Ran is in the GTP-bound state 
whereas cytoplasmic Ran is GDP-bound. The directionality of the nuclear transport 
depends on this RanGTP gradient. 
Transcription factors are synthesized in the cytoplasm and transported into the 
nucleus to activate the transcription of their target genes. The nuclear concentration of 
these transcription factors are modulated by the rates of import and export such that low 
nuclear concentration of these transcription factors are maintained when the expression of 
the targe t genes is no longer needed. Recent studies on the regulation of several 
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transcription factors have shed light on the molecular mechanism governing the 
localization of transcription activators. It is important to note that localization is not the 
only means by which the activity of a transcription factor is regulated, and nuclear 
concentration of a transcription factor does not necessarily correlate with transcriptional 
activation of its target genes. Other layers of regulation may include interactions with 
other transcription factors, post-translational modifications, and DNA binding. 
Regulation of Pho4 
The best-studied example is the yeast transcription factor Pho4. Pho4 is a bHLH 
transcription factor involved in the phosphate starvation response (Oshima 1997). Under 
limiting phosphate conditions, Pho4 interacts with the homeodomain transcription factor 
Pho2 to activate the transcription of PH05 gene, which encodes a secreted acid 
phosphatase. Genetic studies have identified both PH080 and PH085 as negative 
regulators of PH05 gene (Ueda et al. 1975). Much of our understandings of Pho4 
regulation has come from a series of elegant work carried out by O'shea and colleagues. 
First, Pho80 and Pho85 were found to be a cyclin/CDK complex that phosphorylates 
Pho4 when yeast cells are grown in phosphate rich medium, and this phosphorylation 
correlates with negative regulation of PH05 (Kaffman et al. 1994). Later, it was found 
that Pho4 is concentrated in the nucleus when yeast cells are starved for phosphate and is 
predominantly cytoplasmic when cells are grown in phosphate-rich medium. Mutation of 
Pho80/Pho85 phosphorylation sites on Pho4 leads to nuclear concentration of Pho4 and 
partially constitutive expression of PH05 in phosphate-rich medium (O'Neill et al. 1996), 
suggesting that phosphorylation of Pho4 by Pho80/Pho85 promotes its nuclear export. 
Subsequently, the import and export receptors for Pho4 were identified. Pho4 is 
imported by Pse 1, which associates preferentially with the unphosphorylated form of 
Pho4 in vitro (Kaffman et al. 1998b). Pho4 is exported by Msn5, which associates 
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exclusively with the phosphorylated form of Pho4 in the presence of the GTP-bound 
form of yeast Ran in vitro (Kaffman et al. 1998a). Finally, analysis of the Pho4 
phosphorylation sites reveals that these s ites have distinct roles in regulating the activity 
of Pho4 (Komeili and O'Shea 1999). Komeili et al. ( 1999) shows that phosphorylation of 
Pho4 on two sites is necessary and sufficient to promote export of Pho4 in vivo and to 
promote its interaction with Msn5 in vitro. Phosphorylation of a third site blocks its 
interaction with Pse I and prevents its nuclear import. Phosphorylation of the fourth site 
blocks the interaction of Pho4 with Pho2. Taken together, regulation of localization is 
only a part of the multi-layer regulatory system acting on Pho4. 
Regulation of Msn2 
Msn2 and Msn4 are two partially redundant zinc finger transcription factors that 
bind to promoters that carry stress response elements (STREs) and activate the expression 
of a large number of genes involved in stress response and diauxic shift (Martinez-Pastor 
et al. 1996; Schmitt and McEntee 1996; Boy-Marcotte et al. 1998). Similar to Pho4, 
Msn2 was also found to be regulated by localization. Msn2 is predominantly cytoplasmic 
under normal conditions, but is rapidly relocalized to the nucleus when exposed to one of 
several stress condition, such as heat, ethanol, and osmotic shocks (Gomer et al. 1998). 
Recent evidence suggests a role for the TOR (target of rapamycin) signalling pathway in 
promoting the cytoplasmic retention of Msn2/Msn4 through their binding to the 
cytoplasmic 12-3-3 protein BMH2 (Beck and Hall 1999). The mechanism of nuclear 
export of Msn2/Msn4 is not as clear as that of Pho4. Gomer et al. found that nuclear 
localization of Msn2/Msn4 correlated inversely to cAMP levels and protein kinase A 
(PKA) activity. They also show that mutation of conserved PKA phosphorylation sites 
abolished cytoplasmic localization of Msn2 in unstressed cells. However, there is no 
evidence for PKA-dependent phosphorylation of Msn2 in vitro or in vivo. It remains 
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possible that PKA affects Msn2 localization indirectly. Microarray analysis of 
genomewide gene expression in srbl 0-3 cells has identified 173 genes whose expression 
are up two-fold more (Holstege et al. 1998), and many of theses genes are involved in 
stress response and diauxic shift. This raises the possibility that derepression of these 
genes may be due to deregulation of the Msn2/Msn4 transcription factors when Srb 10 
function is lost. To test this, we looked at Msn2 localization in srbl0-3 cells under 
unstressed conditions. The result shows that a subpopulation of the cells exhibits nuclear 
concentration of Msn2 in srbl 0-3 cells, indicating that the tight nuclear exclusion of 
Msn2 normally seen in wild type cells is compromised. This effect is likely to be direct 
because Msn2 is phosphorylated by SrblO in vitro and phosphorylated in vivo in an 
SRBJO-dependent manner in vivo when cells are stressed. Similar to Pho4, Msn2 is also 
exported by the nuclear export receptor Msn5. A key question then is whether Msn4 
export is mediated by Srb 1 0-dependent phosphorylation. Mapping and mutating Srb 10 
phosphorylation sites on Pho4 will be necessary to address this question conclusively. It 
will be interesting to see how much more similarities do Msn2 and Pho4 share in terms of 
the molecular mechanism of their regulation. For example, is Pho80/Pho85 involved in 
Msn2 export? Does the cytoplasmic localization of Pho4 also involve retention through a 
14-3-3 protein? 
Regulation of NF -AT 
Although examples of transcription factor regulation by localization have also 
been found in higher eukaryotes, the mechanisms appear quite different. For example, 
the transcription factor NF-AT (nuclear factor of activated T-cells) has been found to be 
regulated by NES masking. NF-AT is a cytoplasmic transcription factor involved in the 
induction of cytokine genes during T-cell activation. It carries both a NLS and a NES, 
and its localization is regulated in response to intracellular calcium levels (Hogan and 
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Rao 1999). Under resting conditions, calcium levels are low and NF-AT is 
phosphorylated. Phosphorylation masks its NLS and localizes it to the cytoplasm. A rise 
in intracellular calcium levels activates the phosphatase calcineurin, which then binds and 
dephosphorylates NF-AT. Dephosphorylation unmasks the NLS, allowing the import of 
NF-AT into the nucleus (Hogan and Rao 1999). Recent evidence indicates that the 
nuclear import of NF-AT is not sufficient to activate NF-AT target genes because NF-AT 
is constantly exported by the nuclear export receptor Crm 1. Calcineurin suppresses this 
effect by competing for binding to the NES of NF-AT and thereby masking the NES, 
leading to transcriptionally active NF-AT in the nucleus (Zhu and McKeon 1999). A 
different type of NES masking has also been shown to regulate the localization of the 
tumor suppressor protein p53 (Stommel et al. 1999). 
Theme summary 
The following two chapters describe my thesis work. The early phase of my 
thesis work (Chapter 2) was to study the mechanism and regulation of Cdc34-dependent 
ubiquitination of different cellular substrates. We approached this by reconstituting the 
ubiquitination of different substrates in vitro using fractionated yeast extracts. The goal 
was to identify factors necessary and sufficient for Cdc34-dependent ubiquitination and 
therefore better define this ubiquitination pathway. This work was done in parallel to the 
Sic I reconstitution work carried out by other members of the Deshaies laboratory. I 
attempted to characterize the ubiquitination of several other cell cycle substrates, 
including the CDK inhibitor Farl , replication initiation protein Cdc6, the G 1 cyclin Cln2, 
and the transcription factor Gcn4. Studies using fractionated yeast extracts show that 
ubiquitination of all four proteins are dependent on Cdc34 and Cdc4 activities in vitro. 
Furthermore, phosphorylation of all of these proteins is necessary for their subsequent 
ubiquitination by the CDC34 pathway. In vitro results indicate that Cln2/Cdc28 kinase 
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promotes the ubiquitination of Cln2 and Far1; Clb5/Cdc28 kinase promotes the 
ubiquitination of Cdc6; and an unknown kinase promotes the ubiquitination of Gcn4. 
These in vitro experiments provided biochemical evidence that Cdc34/Cdc4 directly 
participate in the ubiquitination of these protein and therefore target them to degradation 
in vivo. Cdc4 was later found to be the F-box component of the SCF ubiquitin ligase 
complex (Feldman et al. 1997; Skowyra et al. 1997). The in vitro work on Far1, Cdc6 
and Cln2 has been published (see Chapter 2). 
Most of thesis work has been focused on the transcription factor Gcn4. An early 
observation indicated that unlike Sic 1, Gcn4 ubiquitination does not require G 1 cyclin 
CDK activity. Instead, Gcn4 ubiquitination appeared to require a different kinase. Much 
effort was spent on identifying the kinase that promotes Gcn4 ubiquitination. As detailed 
in Chapter 3, this effort identified Srb 10 CDK as a physiological kinase that 
phosphorylates Gcn4 and promotes its SCF-dependent ubiquitination in vitro and 
degradation in vivo. Identification of Srb 10 as a Gcn4 kinase put an interest twist on 
Gcn4 regulation and shifted the focus of the project on transcriptional regulation. 
Subsequent studies have identified transcription factor Msn2 as a physiological substrate 
of Srb 10. Srb 10 influences Msn2 localization, likely through direct phosphorylation of 
Msn2. Srb10 is a CDK associated with the RNA polymerase II holoenzyme. Genetic 
and microarray analyses suggest a negative role for Srb10 in regulating a subset of yeast 
genes. However, the exact role of Srb 10 in transcriptional repression has been elusive, 
and current model suggests that the negative effect is achieved through phosphorylation 
of the C-terminal domain of the largest subunit of RNA polymerase II. My studies 
suggest that Srb 10 exerts its repressive effect on specific genes by antagonizing their 
transcriptional activators. Srb10 negatively regulates Gcn4 target genes by promoting 
rapid turnover of Gcn4, and it represses Msn2/Msn4 target genes by promoting their 
export from the nucleus. 
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The physical proximity between Gcn4 and Srb I 0 upon transcriptional activation 
raises an interesting idea. Since promoter binding of Gcn4 recruits RNA polymerase II 
holoenzyme during transcription initiation, phosphorylation of Gcn4 and therefore the 
negative regulation may be confined to the vicinity of the promoter DNA of target genes. 
Preliminary data in Chapter 4 showed that a DNA-binding mutant of Gcn4 was 
significantly stabilized compared to wild-type Gcn4, suggesting that DNA binding is 
required for rapid Gcn4 turnover in vivo. Furthermore, preliminary data also indicated 
that a DNA-binding mutant of Pho4 was localized predominantly in the nucleus under 
phosphate-rich conditions, suggesting that DNA binding is also required for nuclear 
export of Pho4. Taken together, these data posit a general model that the negative 
regulation of transcription factors is coupled to DNA binding. 
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Chapter 2. Ubiguitination of cell cycle re~:ulatory proteins in vitro 
This chapter is compiled using my data from the following published research articles in 
which my work constitute minor contributions, and my name is listed as a co-author in 
each of the articles. Specifically, Figure 1 is from Henchoz, et al. (1997); Figures 2 and 4 
are from Blondel, et al. (2000); and Figure 3 is from Elsasser, et al. (1999). 
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Abstract 
Ubiquitin-mediated proteolysis plays key roles in controlling the cell cycle 
progression in budding yeast. Degradation of the B-type cyclin CDK inhibitor Sic 1 is 
important for G 1/S transition, and degradation of Clb2 is essential for mitotic exit. 
Several other cel1 cycle substrates are also degraded in a cel1 cyc1e-dependent manner. 
These include the Cln/Cdc28 inhibitor Farl, replication initiation factor Cdc6, and the G I 
cyc1in Cln2. Data presented here show that ubiquitination of Far] and Cdc6 in vitro 
requires phosphorylation by the Cdc28 kinase. Cdc34-dependent ubiquitination of al1 
three proteins also requires Cdc4 activity, providing biochemical evidence that 
scpCdc4/Cdc34 directly promotes the ubiquitination of these proteins in vitro. 
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Introduction 
The eukaryotic cell cycle consists of a series of ordered events. Coordination of 
the cell cycle events requires tight control of the regulatory proteins. In recent years, it 
becomes increasingly evident that ubiquitin-dependent proteolysis plays a pervasive role 
in driving the cell cycle machinery (King et al. 1996). The ubiquitin-proteasome 
pathway is the major non-lysosomal degradation pathway in eukaryotes. Proteins are 
targeted to the 26S proteasome for degradation by covalent attachment of multiubiquitin 
chains (Ciechanover et al. 2000). The multi-ubiquitination of substrate proteins is 
mediated by three classes of enzymes: the E1 ubiquitin-activating enzymes, the E2 
ubiquitin-conjugating enzymes, and the E3 ubiquitin ligases. 
The anaphase-promoting complex (APC) and Skpl-cullin-F-box protein complex 
(SCF) are multi-subunit E3 ubiquitin ligases that regulate the cell cycle (Peters 1998): the 
APC promotes entry into anaphase and exit from mitosis, whereas SCF complexes trigger 
G 1-S transition. In budding yeast, entry into S phase requires ubiquitin-dependent 
degradation of the CDK inhibitor Sic 1 (Schwob et al. 1994; Verma et al. 1997a), and 
genetic and biochemical analyses revealed that a high molecular weight complex 
containing Cdc4, Cdc34, Cdc53, Hrt1, and Skp1 is required for its ubiquitination 
(Deshaies 1999). CDC34 encodes an E2 ubiquitin-conjugating enzyme (Goebl et al. 
1988) whereas Cdc4 contains a conserved motif called F-box, which mediates its 
interaction with Skp 1 (Bai et al. 1996). A large family of proteins containing an F-box 
motif has been discovered that may function as adapters to recruit specific substrates to 
the core ubiquitination complex (Patton et al. 1998b), and three of these, Cdc4, Grr1 , and 
Met30, have been shown to assemble into complexes in vivo (Patton et al. 1998a). 
SCPrr1 has been implicated in the degradation of G 1 cyclins, Cln 1 and Cln2 (Barral et al. 
1995; Seol et al. 1999; Skowyra et al. 1999), and the bud emergence protein Gic2 
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(Jaquenoud et al. 1998). Degradation of the CDK-inhibitory kinase Swe I (Kaiser et al. 
1998) and the transcription factor Met4 (Rouillon et al. 2000) are thought to be mediated 
by scpGrrl. 
In addition to Sic I, degradation of the CDK inhibitor Far I and the replication 
initiation factor Cdc6 are also important for proper cell cycle progression. Whereas Sic I 
regulates entry into S phase by inhibiting the Clb/Cdc28 kinases (Mendenhall 1993; 
Schwob et al. 1994), Far] is specifically required to arrest the cell cycle in response to 
mating pheromones by inhibiting the Cln/Cdc28 kinase (Peter and Herskowitz 1994). 
Far I mRNA levels fluctuate through the cell cycle, peaking in G 1 (McKinney et al. 
1993). Farl levels increase several-fold in response to mating pheromones, and the 
protein becomes rapidly phosphorylated by the MAP kinase Fus3 (Peter et al. 1993). To 
study the post-translational regulation of Farl, Peter and Herskowitz (1994) have isolated 
a mutant Far I (Farl-22), which arrests cells even in the absence of mating pheromones. 
Whereas wild-type Farl was only present in the G 1 phase, Farl-22 was found in the 
nucleus throughout the cell cycle. Farl-22 carries a Ser-87 to Pro-87 mutation, and Ser-
87 was located to a consensus phosphorylation site for Cdc28 kinase. Far I is stabilized 
in temperature-sensitive cdc34 and cdc53 mutants at the non-permissive temperature, 
suggesting Farl is degraded by the SCF pathway (Henchoz et al. 1997). We show here 
that Farl is ubiquitinated in a Cdc34/Cdc4-dependent manner in vitro and the 
ubiquitination requires the phosphorylation of Far I at Ser87 by Cln/Cdc28 kinase. 
InS phase, cells must coordinate DNA replication such that every origin of 
replication fires only once per cell cycle. Cdc6 is part of the pre-replicative complex 
(prePC), which also includes the six-subunit origin recognition complex (ORC), the six 
Mcm proteins, and Cdc45 (Newlon 1997). Once the origin fires, the pre-RC is lost from 
the origin and does not reassemble until the end of the following mitosis (Diffley et al. 
1994). Pre-RCs normally assemble during G I phase and can not assemble later in the 
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cell cycle because the Clb/Cdc28 kinases prevents pre-RC formation (Dahmann et al. 
1995). Thus protein phosphorylation by Clb/Cdc28 may be an important means to 
prevent spurious replication. Cdc6 has been shown both to associate with and to be 
phosphorylated by Clb/Cdc28 (Elsasser et al. 1996). Yeast cells arrested in S or G2 
degrade bulk Cdc6 rapidly, but Cdc6 is stable as cells progress through G 1 (Piatti et al. 
1995; Drury et al. 1997; Sanchez et al. 1999). The cell cycle-dependent instability of 
Cdc6 could mean that Cdc6 is degraded in a Clb/Cdc28-dependent manner. In vivo 
studies indicate that Cdc6 is stabilized in cdc34 , cdc4, and cdc53 mutants (Drury et al. 
1997; Sanchez et al. 1999), suggesting a role for SCFcdc4 in Cdc6 turnover. A mutant 
alleles of Cdc6 bearing multiple mutations in the putative Cdc28 phosphorylation sites in 
the Cdc6 N-terminal Cdc28-binding domain was strongly stabilized compared to wild-
type Cdc6, suggesting that phosphorylation of Cdc6 by Cdc28 kinase is important for its 
turnover (Elsasser et al. 1999). We show here that both Cdc34 and Cdc4 are required for 
Cdc6 ubiquitination in vitro, providing biochemical support for the in vivo findings. 
Furthermore, phosphorylation of Cdc6 by Clb5/Cdc28 kinase is sufficient to promote 
Cdc34-dependent ubiquitination. 
G 1 cyclins Cln 1 and Cln2 are constitutively unstable proteins, and they 
accumulate during the G 1 phase and become maximal during the late G 1 phase as cells 
transit the Start (the point as which cells commit to completion of a cell cycle). G 1 cyclin 
abundance is important in determining the timing of cell cycle initiation, and their 
instabilities are therefore critical for proper regulation of cell cycle progression. 
Degradation of G 1 cyclins Cln2 and Cln3 are CDC34-dependent (Deshaies et al. 1995; 
Yaglom et al. 1995). Phosphorylation of these proteins on Cdc28 consensus sites is also 
required for their rapid degradation (Yaglom et al. 1995; Lanker et al. 1996). Several 
other proteins have also been implicated in Cln instability, including Skp 1 (Bai et al. 
1996), Cdc53 (Willems et al. 1996), and Grr1 (Barra! et al. 1995). Grrl is a F-box 
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proteins that binds phosphorylated Cln 1 and Cln2 in vitro (Skowyra et al. 1997). Cln I 
and Cln2 ubiquitination have been reconstituted in vitro using purified scp:>rrl that also 
contains the fourth subunit Rbx 1/Grrl (Seol et al. 1999; Skowyra et al. 1999). Taken 
together, current evidence indicates that G 1 cyclins Cln 1 and Cln2 are targeted for 
degradation by the SCF'rr' pathway. Interestingly, in vitro ubiquitination of Cln2 using 
fractionated yeast extracts shows that SCFCdc4 can also ubiquitinate Cln2 despite the lack 
of physiological evidence for its role in promoting Cln2 turnover. 
Results 
In vitro ubiquitination of Far] depends upon Cdc34 , Cdc4, and eye/ins 
To determine whether Far1 is ubiquitinated by the GI-S ubiquitination system, we 
in vitro-translated Fari in rabbit reticulocyte lysates (Fig. IA) or wheat germ extracts 
(Fig. IB) in the presence of e5S]methionine and added DEAE-fractionated yeast extracts. 
These extracts are devoid of the G 1 cyclins Cln 1, Cln2, and Cln3 and are depleted of 
Cdc34 (Fig. 1 A) or lack functional Cdc4 (Fig. I B). Addition of Far I, purified GST -Cln2, 
ubiquitin (Ub), and Cdc34 resulted in accumulation of slower migrating forms of Far I 
(Fig. 1 A, lane 2). Methylated ubiquitin (meUb), which blocks formation of 
multiubiquitin chains by preventing Ub-Ub ligation (Hershko and Heller I985), 
prevented accumulation of these high molecular weight forms of Far] (Fig. I A, lane 3), 
showing that they were ubiquitinated. Ubiquitination in vitro was dependent on Cdc34 
(Fig. IA, lane 4) and Cdc4 (Fig. lB). DEAE-fractionated extracts prepared from cdc4ts 
mutants failed to ubiquitinate wild-type Far1 (Fig. lB, lane 1 ). Addition of purified 
Cdc34 (Fig. lB, lane 1) or baculovirus-infected insect cell lysate containing Cdc4 (Fig. 
1 B, lane 2) alone did not restore activity of the extract. However, addition of Cdc34 and 
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Cdc4 together restored Farl ubiquitination (Fig. IB, lane 3). As a control, insect lysate 
containing Cdc28 and Cdc34 did not lead to ubiquitination of Farl (Fig. I B, lane 4 ). 
Ubiquitination of Far I was also dependent on the addition of the G 1 cyclin Cln2 (Fig. 
IB, lane 5), indicating that Farl may need to be phosphorylated by Cdc28/Cln2 to be 
recognized by the Cdc34-dependent ubiquitination system. Alternatively, Cdc28/Cln2 
may be necessary to activate a component of the ubiquitination machinery. Importantly, 
no ubiquitination could be detected on Farl-22 (Fig. IA, lane 7), suggesting that the 
increased half-life of Far I -22 in vivo results from its failure to be ubiquitinated and 
degraded. These results show that wild-type Farl , but not Far I -22, is ubiquitinated in a 
Cdc34- and Cdc4-dependent manner in vitro and further suggest that ubiquitination of 
Farl may require a phosphorylation event governed by the Cdc28/Cln2 kinase. 
Cytoplasmic F arl-nlsl and F arl-nlsl lnls2 are efficiently ubiquitinated by reconstituted 
scpC"'"4 in vitro 
Farl proteins containing point mutations in its major nuclear localization signals 
(NLSs) (Farl-nlsl, Farl-nlsl/nls2) and a double mutant Farl-nlsl/22 are localized to the 
cytoplasm. These proteins have 2.5-5-fold longer half-life than wild-type Farl protein 
(Blonde! et al. 2000). Bondel et al. (2000) proposed that these proteins are stabilized 
because Cdc4 is exclusively localized to the cell nucleus. However, to exclude the trivial 
possibility that the mutations introduced into Farl-nls l and Farl-nlsl/nls2 may interfere 
with its ubiquitination, we carried out in vitro ubiquitination experiments using 
reconstituted SCFcctc4 and in vitro-translated 35S-labeled wild-type or mutant forms of 
Farl (Figure 2). Clearly, SCFcdc4 was able to ubiquitinate wild type Farl (lanes 1-5), 
Farl-nlsl (lanes 6-8) and Farl-nlsl/2 (lanes 12-14) with similar efficiency. The smear 
of slower migrating forms represents ubiquitinated species of Farl, because addition of 
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methyl-ubiquitin (Me-Ub), which cannot be extended into multi-ubiquitin chains 
(Hershko and Heller 1985), competes with the formation of these high molecular weight 
forms. As expected, ubiquitination required the addition of purified Cdc28/Cln2 (kinase) 
and a phosphorylatable serine 87 (lanes 9-11 ), confirming that ubiquitination of Far l-
nlsl or Farl-nls 1/2 was dependent on phosphorylation of serine 87 by Cdc28/Cln2. We 
conclude that stabilization ofFar1-nlsl and Far1-nlsl/nls2 in vivo is not due to a defect 
in its ubiquitination caused by these mutations. 
CDC4 and CDC34 are required for phosphorylation-dependent ubiquitination of Cdc6 in 
vitro 
Recent demonstration that Cdc6 is stabilized in a cdc4 sic] ,1 strain suggested that 
SCFcdc4 targets phosphorylated Cdc6 for ubiquitination rather than acting indirectly by 
degrading Sic l p and thus activating Clb/Cdc28 kinase. Our results confirm the direct 
targeting of Cdc6 by SCpCdc4 action. As shown in Figure 3, the appearance of Cdc6 
conjugates depends on addition of Cdc34 (compare lanes 4 and 5). To compare Cdc6 
ubiquitination in the presence and absence of Cdc4, fractionated extracts prepared from 
both wild type and cdc4 cells were used. Cdc6 conjugates were not obtained when using 
fractionated cdc4 extracts (Fig. 3, compare lanes 5 and l 0), but if insect cell lysate 
containing recombinant Cdc4 was added, ubiquitination of Cdc6 was restored (Fig. 3, 
compare lanes 10 and 12). Naturally, Cdc6p modification still required addition of 
Cdc34 (Fig. 3, compare lanes 11 and 12). We conclude that the slowly migrating species 
are ubiquitinated Cdc6, because their appearance depends on Cdc34 and Cdc4. Although 
a requirement for Cdc34 and Cdc4 in this reaction could derive from a requirement to 
degrade Sic 1, we have determined that the Clb5/Cdc28 kinase added to these reactions is 
in considerable excess over Sicl . We therefore propose that Cdc34 and Cdc4 are directly 
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required for Cdc6 destruction and that Cdc4 is required for the recognition of Cdc6 as a 
substrate for ubiquitination. This model is consistent with the observations that Cdc6 and 
Cdc4 interact in a two-hybrid system (Drury et al. 1997) and that Cdc6 is stable in G2 
phase cells in a cdc4 sicl L1 strain (Sanchez et al. 1999). 
Cdc34-dependent ubiquitination ofC!n2 in yeast extracts also requires Cdc4 
Ubiquitination of 35S-labeled Cln2 was carried out in fractionated yeast extracts 
prepared from wild-type (Fig. 4, lanes 2 and 3) and cdc4 (Fig. 4, lanes 4-8) strains. Wild-
type extract was able to support Cln2 ubiquitination when purified Cdc34 was added 
(lane 2), and the ubiquitination was confirmed by the addition of methyl-ubiquitin (lane 
3). To our surprise, Cln2 ubiquitination is defective in cdc4 extracts (lane 5). 
Furthermore, addition of baculovirus-infected insect lysate containing expressed Cdc4 
was able to rescue the defect (lane 7). This result suggests that scp<:ctc4 is able to 
ubiquitinate Cln2, at least in vitro. 
Discussion 
Ubiquitin-mediated degradation plays a key role in regulating cell cycle 
progression in budding yeast. Degradation of Sic 1 by Cdc34/SCpectc4 pathway triggers 
G 1-S transition (Schwob et al. 1994; Feldman et al. 1997; Skowyra et al. 1997). Work 
shown here expands the repertoire of the scpCdc4 substrates, and provides biochemical 
evidence that the scpCdc.:~ pathway may regulate Farl and Cdc6 turnover. It also 
underscores substrate phosphorylation as a potential hallmark of SCFcctc4-dependent 
ubiquitination (Fig. 5). 
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Degradation ofF arl 
Far I accumulates during G 1 phase of the cell cycle. This expression pattern is 
achieved in part by transcriptional regulation ofF ARJ, which is restricted to G 1 and late 
M phase of the cell cycle (McKinney et al. 1993). It is required to arrest the cell cycle in 
the presence of mating pheromones but is not necessary for the normal cell cycle 
progression (Chang and Herskowitz 1990). Far1 is degraded at the G I to S transition and 
remains unstable until cells exit from mitosis (Henchoz et al. 1997). The degradation of 
Far] is physiologically relevant during the yeast mating. Cells arrested with a-factor that 
are unable to find a mating partner adapt to the presence of mating pheromones and 
resume cell division. Reentry into the cell cycle requires the degradation of Farl: Cells 
that produce nondegradable Farl are unable to properly activate the Cln/Cdc28 kinase 
after release form a factor and, as a consequence, fail to recover efficiently (Henchoz et 
al. 1997). Henchoz et al. (1997) also show that Far I degradation is dependent on Cdc34, 
Cdc 53, and specific phosphorylation at Ser87. The CDC4-dependence of Farl 
degradation has not been clearly demonstrated in vivo. By analogy to Sicl degradation, 
it is likely that Far I degradation is dependent on Cdc4. In vitro, Far] ubiquitination 
requires activities of both Cdc34 and Cdc4, and the reaction also requires 
phosphorylation by Cln/Cdc28 (Fig. 1 ). This experiment lends support to the hypothesis 
that Farl is degraded by the Cdc34/Cdc4-dependent ubiquitination pathway. With the 
subsequent identification of SCF complexes, it is feasible to reconstitute Farl 
ubiquitination using purified recombinant SCFcdc4 (Fig. 2). The experiment in Fig. 2 
demonstrates that purified SCFcdc4 is sufficient to ubiquitinate Far1, and the reaction 
efficiency is higher than that observed in yeast extracts (compare Figs. 1 and 2). 
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Degradation of Cdc6 
The rapid degradation of Cdc6 at G 1-S is conserved for homologues in other 
eukaryotes, although not in all , suggesting periodic degradation of Cdc6 is important for 
regulation of cell cycle progression (Drury et al. 1997; Williams et al. 1997; Hua and 
Newport 1998; Saha et al. 1998). There is strong evidence arguing for a role of SCFcctc4 
in promoting the degradation of Cdc6 in vivo. First, Cdc6 interacts with Cdc4 in a two-
hybrid assay and is stabilized in cdc4, cdc34, cdc53 mutants (Drury et al. 1997). Second, 
Cdc6 ubiquitin conjugates are observed in vivo and are dependent on Cdc4 function 
(Sanchez et al. 1999). Phosphorylation of certain N-terminal Cdc28 consensus sites is 
also important for rapid Cdc6 turnover (Elsasser et al. 1999). However, there has been no 
biochemical evidence that SCFcctc4 directly ubiquitinates Cdc6. The experiment shown in 
Fig. 3 shows that both Cdc34 and Cdc4 are required for the ubiquitination of Cdc6 in 
vitro. Furthermore, phosphorylation of Cdc6 is required for its subsequent ubiquitination. 
When phosphorylated by Clb5/Cdc28, Cdc6 becomes competent for ubiquitination by the 
Cdc34/Cdc4 ubiquitination machinery. Although Cdc6 ubiquitination has yet to be 
reconstituted using purified proteins, it is a reasonable assumption that the reaction will 
likely to proceed with higher efficiency than that shown in Fig. 3. 
Degradation ofCln2 
Cyclins are inherently unstable prote ins, and their instability is important for the 
regulation of CDK activities, which drive the cell cycle engine. Cln2 is unstable in G I 
phase, and its instability is required for proper regulation of Start (Schneider et al. 1998). 
Subunits of the SCPrr1 have been implicated in Cln2 turnover (Barral et al. 1995; Bai et 
al. 1996; Willems et al. 1996). It is proposed that phosphorylation of Cln2 by Cdc28 
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couples activation of the Cln2/Cdc28 kinase to degradation of the Cln2 polypeptide and 
thereby renders Cln2-activated CDK activity self-limiting (Lanker et al. 1996). In vitro, 
Cln2 was hyperphosphorylated upon incubation with yeast extracts, which contain Cdc28 
(Fig. 4 ). Ubiquitination of Cln 1 (Skowyra et al. 1999) and Cln2 (Seol et al. 1999) have 
been reconstituted with purified scprrl after the identification of Rbx 1/Hrt1. Although 
genetic and biochemical evidence indicates that Cln2 is predominantly ubiquitinated in 
vivo by scprrl. ubiquitination of Cln2 in yeast extracts suggests that SCFCdc4 may also be 
able to ubiquitinate Cln2 (Fig. 4). It is surprising to see that Cln2 ubiquitination was 
defective in cdc4 extracts, but could be restored with recombinant Cdc4 (Fig. 4). To 
correctly interpret this result, it would be necessary to see if Cln2 ubiquitination can be 
reconstituted using purified SCFcdc4 • If scpCdc4 is sufficient to ubiquitinate Cln2, it would 
then suggest that the fractionated cdc4 extracts lack both Cdc4 and Grrl activities. Two 
pieces of evidence suggest that SCFcdc4 may have a minor role in Cln2 turnover. First, 
Cln2 was weakly stabilized in cdc4 mutant cells in vivo (tl/2 = 4 min in wild type and 
~7.5 min in cdc4-l cells; R. Deshaies, personal communication). Second, Cdc4 binds 
phosphorylated Cln2 in vitro, albeit weaker than Grrl does (Skowyra et al. 1997). It is 
possible that SCFcdc4 is capable of ubiquitinating Cln2, but it is not the physiological 
choice. Work from Blonde] et al. (2000) suggests that there may be compartment-
specific targeting of SCF substrates depending on the localization of the F-box receptor 
proteins. 
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Materials and Methods 
Yeast Strains 
The yeast strains used in this study are RJD885 (ura3 leu2 trpl clnl ::URA3 
cln2::LEU2 cln3::URA3 leu2::GAL-CLN3::LEU2 pep4::TRPJ cdc28::CDC28-
HA: :HIS3 MATa) and RJD893 (cdc4 ura3 leu2 t1pl clnl ::URA3 cln2::LEU2 
cln3::URA3leu2::GAL-CLN3::LEU2 pep4::TRP1 cdc28::CDC28-HA::HIS3 MATa). 
Recombinant proteins 
GST-Cln2 and Cdc34 were expressed and purified from E. coli as described 
previously (Banerjee et al. 1993; Deshaies and Kirschner 1995). Hi'6Uba 1 was purified 
from yeast as described previously (Feldman et al. 1997). Ubiquitin was obtained from 
Sigma, and methyl-ubiquitin was kindly provided by R. King. Cln2, Cdc28, Clb5/Cdc28, 
and Cdc4 were expressed in baculovirus-infected insect cells, and celllysates were 
prepared as previously described (Verma et al. 1997c; Reynard et al. 2000). scpCdc4 
complex (PyHACdc4-Cdc53-Skp 1-Hrtl ) was expressed in Sf9 insect cells and bound to 
polyoma (Py) beads as described (Seol et al. 1999). The polyoma beads were eluted with 
polyoma peptide and the eluate was used to supply SCP:dc4 activity in Fig. 2. 
Preparation of yeast extracts 
Preparation of DEAE-fractionated yeast extracts was carried out as previously 
described (Verma et al. 1997b; Verma et al. 1997c). The 250 mM NaCl eluate was used 
in the assays containing yeast extracts. This fraction was essentially devoid of Cdc34, 
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which eluted at 500 mM NaCl. It was also depleted ofG1 cyclins by genetic trickery. 
Strain RJD885 was used for wild-type yeast extract, and strain RJD893 was used for cdc4 
extracts. 
Preparation of substrates 
Wild-type and mutant FARJ (Fig. 1A) and wild-type CDC6 (Fig. 3) transcription 
templates were generated from plasm ids containing ful1-length F ARJ or CDC6 sequence 
by PCR using a 5' oligonucleotide containing a T7 RNA polymerase promoter (Verma et 
al. 1997b). Alternatively, linearized plasmids carrying T7-directed wild-type or mutant 
FARJ(Figs. 1B, 2) and wild-type CLN2 (Fig. 4) were used. The templates were then 
transcribed and translated in reticulocyte lysates (F ARJ in Fig. 1 A and CLN2) or wheat 
germ extracts (F ARJ in Fig. 1 B and CDC6) according to the manufacturers instructions 
(Promega) to generate ['5S]methionine-labeled substrates. 
Ubiquitination reactions 
In Figs. 1, 3, and 4, the 250mM DEAE eluate (see above) was used to supply 
ubiquitination activity, and the reactions were carried out essentially as previously 
described (Verma et al. 1997c). Briefly, the radiolabeled substrate (1 !-t-1) was incubated 
in 10 !-t-1 of reaction mixture containing wild-type or mutant yeast extract (1 00 !A-g), 
reaction buffer containing protease inhibitors, A TP mix, ubiquitin (1 0 !A-g), and Cdc34p 
(I 00 ng). For reactions with cdc4 extracts, 0.5 f.!l of insect lysate (-5 mg/ml) containing 
Cdc4p or Cdc28p was used where indicated. In Fig. 2, purified recombinant SCFcctc'~ (see 
above) was used. In a complete reaction, the yeast extracts were replaced by purified 
Uba1 (50 ng), Cdc34 (100 ng) and scpCctc4 complex (50- 100 ng). Cdc28/Cln2 kinase 
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activity was supplied as insect lysate (2 flg total protein) containing expressed Cln2myc, 
GST -Cdc28, Cks 1, and Cak 1 (Seol et al. 1999). Insect lysate containing expressed Cln2 
alone was used to represent absence of Cdc28-Cln2 kinase activity. All reactions were 
incubated at 24°C for 60 min, terminated by the addition of SDS-PAGE sample buffer, 
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Figure 1. Wild-type Far1 but not Farl-22 is ubiquitinated in vitro. 
Wild-type Farl (A, lanes 1-5; B, lanes 1-4) orFarl-22 (A, lanes 6-10) synthesized in 
vitro in the presence of e5S]methionine was incubated in fractionated extracts prepared 
from cells lacking CLN1,2, and 3 (A) or cells deleted for CLN1,2, and 3, which are also 
temperature-sensitive for cdc4 (B). These extracts are devoid of Cdc34 and contain low 
levels of ubiquitin. 
(A) Wild-type Farl was ubiquitinated if the extract was supplemented with the addition 
of Cdc34, GST-Cin2, and ubiquitin (lane 2). Reduced accumulation of high molecular 
weight ubiquitin conjugates was observed if methyl-ubiquitin was added to block chain 
extension (lane 3). No ubiquitination was observed with Farl-22 (lanes 6-1 0). 
(B) Ubiquitination of wild-type Far] p was dependent on Cdc4 (lanes 1 and 4). 
Ubiquitination in cdc4 extracts was restored only by the simultaneous addition of purified 
Cdc34 and baculovirus-infected insect lysate containing Cdc4 (lane 3). The addition 
of insect lysate containing Cdc28 serves as a specificity control (lane 4 ). 
Fig. 2 
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Figure 2. Ubiquitination of wild-type and mutant Farl by SCFcctc4 in vitro. 
Wild type (lanes 1- 5) or the indicated Farl mutants (lanes 6-14) were in vitro translated 
in the presence of [35S]methionine and incubated as indicated with reconstituted scp<:ctc4 
(SCF), Cdc28/Cln2 (Kinase) and ubiquitin (Ub) as described in Materials and Methods. 
Where indicated, Me-ubiquitin instead of ubiquitin was added as a control (Me-Ub). The 
arrows point to the position of unphosphorylated (Farl) and phosphorylated Farl (P-
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Figure 3. In vitro ubiquitination of Cdc6 is dependent on Cdc4. 
35S-Labeled Cdc6 was prepared by in vitro translation as described in Materials and 
Methods and used as a substrate for in vitro ubiquitination reactions. Lane I contains the 
input 35S-labeled Cdc6 without extract. Extract prepared from RJD885 cells (wild type 
for ubiquitination components) was used in the ubiquitination reactions in lanes 2-6. 
Extract from RJD893 cells (cdc4 and isogenic to RJD885) was used in reactions in lanes 
7-12. The complete ubiquitination reaction (lanes 5 and I 0) included DEAE-fractionated 
extract of G 1-arrested cells, purified Cdc34, insect cell lysate containing Clb5/Cdc28 
kinase, an A TP-regenerating system, salts, and ubiquitin. The reactions in lanes 6, 11 , 
and 12 were supplemented with recombinant Cdc4 purified from insect cells. Cdc34 and 
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Figure 4. scpCdc4 is able to ubiquitinate Cln2 in vitro. 
In vitro-translated e5S]methionine-labeled Cln2 (lane 1) was incubated in DEAE-
extracts prepared from wild-type (lanes 2 and 3) or cdc4-l cells (lanes 4-8), 
complemented where indicated(+) with ubiquitin (Ub), and bacculo-expressed Cdc34, 
Cdc4 and Cdc28. In lane 3, methylated ubiquitin (Me-Ub) was added instead of ubiquitin 
to compete for poly-ubiquitination. The arrow points to unphosphorylated (Cln2) or 
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Figure 5. A model for the degradation of Farl, Cdc6, and Cln2. 
Phosphorylation of these proteins by Cdc28 CDK, either in the form of Cln/Cdc28 for 
Farl , Clb/Cdc28 for Cdc6, or autophosphorylation by cognate Cdc28 for Cln2, targets 
them for SCF-dependent ubiquitination. Phosphorylated Farl and Cdc6 are recognized 
by scpCdc4 complex whereas phosphorylated Cln2 is recognized by SCfPrrl. However, 
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Abstract 
The budding yeast transcriptional activator Gcn4 is rapidly degraded in an 
scpCctc4-dependent manner in vivo. Upon fractionation of yeast extracts to identify 
factors that mediate Gcn4 ubiquitination, we found that Srb I 0 phosphorylates Gcn4 and 
thereby marks it for recognition by scpectc4 ubiquitin ligase. SrblO is a physiological 
regulator of Gcn4 stability because both phosphorylation and turnover of Gcn4 are 
diminished in srbl 0 mutants. Gcn4 is almost completely stabilized in srbl 011 pho85f1 
cells, or upon mutation of all SrbiO phosphorylation sites within Gcn4, suggesting that 
the Pho85 and Srb I 0 CDKs conspire to limit the accumulation of Gcn4. The multistress 
response transcriptional regulator Msn2 is also a substrate for Srb I 0 and is 
hyperphosphorylated in an SrblO-dependent manner upon heat stress-induced 
translocation into the nucleus. Whereas Msn2 is cytoplasmic in resting wild type cells, 
its nuclear exclusion is partially compromised in srbl 0 mutant cells. Srb I 0 has been 
shown to repress a subset of genes in vivo, and has been proposed to inhibit transcription 
via phosphorylation of the C-terrninal domain of RNA polymerase II. We propose that 
Srb I 0 also inhibits gene expression by promoting the rapid degradation or nuclear export 
of specific transcription factors. Simultaneous down-regulation of both transcriptional 
regulatory proteins and RNA polymerase may enhance the potency and specificity of 
transcriptional inhibition by Srb I 0. 
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Introduction 
Precise modulation of intracellular protein concentration is an important means by 
which diverse cellular processes are regulated. One way cells effectively achieve this is 
through proteolysis of key regulatory proteins. The ubiquitin system is the major 
cytoplasmic pathway by which proteins are degraded. Ubiquitin-mediated degradation of 
cellular proteins involves attachment of ubiquitin chains to substrate proteins, which are 
subsequently targeted for degradation by the 26S proteasome (Ciechanover et al. 2000). 
Assembly of a multiubiquitin chain upon a substrate typically requires three classes of 
enzymes: the ubiquitin-activating enzyme (El ), a ubiquitin-conjugating enzyme (E2), and 
a ubiquitin ligase (E3). TheE 1 enzyme activates ubiquitin in an ATP-dependent manner 
by linking to its C terminus via a thioester bond. The E2 enzyme accepts the 
thioesterified ubiquitin and transfers it to a lysine residue of the target protein. This step 
usually requires assistance from an E3 enzyme. There are potentially 13 E2-like proteins 
in budding yeast. In contrast, there are two distinct classes of E3s: the HECT domain 
family and the RING domain family (Deshaies 1999; Seol et al. 1999; Jackson et al. 
2000). The RING domain family of E3s includes multimeric complexes such as SCF and 
anaphase-promoting complex/cyclosome (APC/C), as well as single subunit ligases like 
Ubrl. Whereas HECT E3s act as a direct intermediary by accepting ubiquitin from E2 
and transferring it to substrate, RING-based E3s are thought to catalyze ubiquitination by 
enabling the direct transfer of ubiquitin from E2 to substrate (Seol et al. 1999). 
Regardless of their mechanism of action, E3s typically bind directly to E2 and to 
substrate, suggesting that they provide substrate specificity in cellular ubiquitination 
reactions. 
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One salient example of how proteolysis can provide a regulatory switch stemmed 
from genetic analysis of the G /S transition in budding yeast (Schwob et al. 1994 ). Cells 
harboring temperature-sensitive mutations in SKP 1, CDC 53, and CDC4 arrest in G 1 
phase at the nonpermissive temperature because they fail to degrade the S phase 
cyclin/cyclin-dependent kinase (CDK) inhibitor Sicl (Schwob et al. 1994; Bai et al. 
1996). Subsequent in vitro reconstitution of Sic 1 ubiquitination led to the identification 
of SCFCdc4, the prototype of the SCF (for .S.kp, Cdc53/Cullin, .E-box receptor) family of 
ubiquitin ligases (Feldman et al. 1997; Skowyra et al. 1997; Verma et al. 1997a). 
Recently, Hrtl (also known as Rocl and Rbx 1), an essential fourth subunit of the SCF 
complex, was identified (reviewed in Deshaies 1999). The SCF family of ubiquitin 
ligases is potentially large given that the yeast genome encodes at least 17 potential F-box 
receptor subunits (Patton et al. 1998b ), and at least two other SCF complexes-SCPrr' and 
SCFMe'30-have been identified in budding yeast (Patton et al. 1998a). Cdc34 appears to be 
the primary E2 enzyme that interacts with SCF complexes and catalyzes ubiquitination of 
their substrates in budding yeast. 
Besides Sic 1, the CDK inhibitor Farl (Henchoz et al. 1997) and the replication 
initiation protein Cdc6 (Drury et al. 1997; Elsasser et al. 1999) have been shown to be 
substrates of SCFcctc4 • A common feature in the ubiquitination of scpCctc4 substrates is 
that they must be phosphorylated by the major cell cycle CDK, Cdc28 (Henchoz et al. 
1997; Verma et al. 1997a; Elsasser et al. 1999). Phosphorylation appears to serve as a 
general signal that promotes binding of the F-box receptor Cdc4 to the substrates 
(Feldman et al. 1997; Skowyra et al. 1997). To investigate the generality of the 
Cdc34/SCpectc4 pathway, we initiated biochemical analysis of the roles of these proteins in 
Gcn4 ubiquitination. Gcn4, a transcription activator involved in the regulation of amino 
acid and purine biosynthetic genes (Hinnebusch 1992) is very unstable, and its 
degradation is dependent on Cdc34 and proteasome function (Kornitzer et al. 1994). Very 
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recently, it was shown that Gcn4 is stabilized in cdc4, cdc53 and skpl temperature-
sensitive mutants and in pho85!1 cells (Meimoun et al. 2000). This suggests that SCP:dc4 
contributes to the rapid degradation of Gcn4 in vivo and that a CDK other than Cdc28 is 
involved in Gcn4 degradation. However, there is no biochemical evidence to date that 
either SCFCdc4 or Pho85 directly promotes ubiquitination of Gcn4. 
Here we provide evidence that the Srb 10 CDK of the SRB/mediator complex 
phosphorylates both Gcn4 and the multistress response transcription factor Msn2. 
Whereas Srb10 targets Gcn4 for scpCdc4-dependent degradation, it helps enforce the 
nuclear exclusion of Msn2. It has been proposed that Srb 10 negatively regulates 
transcription of certain genes by binding and phosphorylation of the C-terminal domain 
(CTD) of the largest subunit of RNA polymerase II (Hengartner et al. 1998). Our results 
suggest that Srbto can also repress the transcription of specific genes by directly 
antagonizing transcriptional activators. 
Results 
Ubiquitination ofGcn4 in yeast extracts 
Our in vitro studies on Gcn4 ubiquitination were prompted by the observation that 
Gcn4 turnover in vivo depends on Cdc34 (Kornitzer et al. 1994). As a first step toward 
understanding the mechanism and regulation of Gcn4 turnover, we set out to reconstitute 
Gcn4 ubiquitination in vitro. Ubiquitination of [35S]methionine-labeled Gcn4 was 
evaluated in G 1-cyclin-depeleted whole cell yeast extracts as described for Sicl (Verma 
et al. 1997a). Although ubiquitination of Sic I required the addition of GST-Cln2 to 
supply Cdc28 kinase activity (Fig. I A, lanes 6,7), ubiquitination of Gcn4 did not (lanes 
2,3). Multiubiquitination of both substrates was confirmed by the addition of methyl-
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ubiquitin (lanes 4 and 8), a chain-terminating derivative of ubiquitin. Concomitantly with 
ubiquitination, Gcn4 exhibited a characteristic molecular weight (MW) upshift upon 
incubation in yeast extract (compare lanes 1 ,2). To test if this modification was due to 
phosphorylation, we first incubated Gcn4HA with a yeast extract fraction enriched for this 
activity, and then immunoprecipitated Gcn4HA and treated it with calf intestinal alkaline 
phosphatase (ClAP). As shown in Fig. 1 B , ClAP treatment reversed the MW shift of 
Gcn4, indicating that it arises from phosphorylation. 
The results above suggested that Gcn4 might be targeted for ubiquitination by a 
novel pathway. Alternatively, a protein kinase besides Cdc28 may be able to direct Gcn4 
to the SCF pathway. To distinguish between these possibilities, we fractionated whole 
cell extract from mutant cdc4'' cells into a protein kinase fraction and an SCF-containing 
fraction (the SCF fraction lacks the E2 Cdc34; Verma et al. 1997a). As shown in Fig. 
I C, multiubiquitination of Gcn4 occurred only when both yeast fractions and exogenous 
Cdc34 and Cdc4 were added. Since ubiquitination of Sic1 did not require the 'kinase 
fraction' (data not shown), we concluded that Gcn4 must be phosphorylated by an 
unknown protein kinase before it can be ubiquitinated by the SCFcctc4/Cdc34 pathway 
Identification of the SrblO subunit of RNA Polymerase II holoenzyme as a Gcn4 kinase 
To identify the activity required for Gcn4 ubiquitination in vitro, we first 
attempted to purify this activity by conventional column chromatography. We used both 
Gcn4 kinase assays and ubiquitination assays to monitor this activity during purification. 
Unfortunately, we did not purify enough activator to obtain protein sequence. However, 
upon partial purification (Fig. 2A), we identified a high molecular weight (MW) Gcn4 
kinase activity that co-fractionated with the ubiquitination-promoting activity (Fig. 2B). 
Note that although there are two contaminating low-MW Gcn4 kinases that peak in 
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fractions 11 and 15, neither of these fractions can sustain ubiquitination of Gcn4 by 
scpCdc4 • We suspected the kinase activity was a CDK since the Cdc28 CDK is required 
for SCFcdc4-dependent ubiquitination of Sic I, Far], and Cdc6. Given that Kin28 and 
Srb 10, both of which are components of the RNA polymerase II holoenzyme (Myer and 
Young 1998), are the only CDKs known to reside in a high MW complex, we tested if 
either of these kinases was responsible for the purified activity. Extract fractions 
enriched for the high MW Gcn4 kinase activity were prepared from SRBJO and srbl0/1 
cells and tested for their ability to support Gcn4 ubiquitination by Cdc34 and purified 
recombinant scpCdc4 complex. As shown in Fig. 2C, the kinase fraction from SRBJO but 
not srbl 0!1 cells supported Gcn4 ubiquitination. In contrast, we did not observe any 
defect when the kinase fraction was prepared from a kin28'·' strain (data not shown). 
Taken together, these observations suggest that Gcn4 is directly ubiquitinated by 
Cdc34/SCP:dc4 , and that the Srb 10 subunit of RNA Polymerase II holoenzyme is the 
predominant protein kinase in yeast extract that is able to specify ubiquitination of Gcn4 
by this pathway. 
SrblO, but not Kin28, phosphorylates Gcn4 in vitro and targets it for SCF-dependent 
ubiquitination 
Since both SrblO and Kin28 associate with the RNA polymerase II holoenzyme 
complex (Myer and Young 1998), we next tested if either Srb 10 or Kin28 could directly 
phosphorylate Gcn4 by immunoprecipitating each of the kinases from yeast whole cell 
extracts and performing kinase assays using purified Gcn4 expressed in E. coli. Anti-
myc immunoprecipitates from SRBJO"'.rcY cells exhibited potent Gcn4 kinase activity, 
whereas those from KIN28"'Y'9 cells had little or no activity (Fig. 3A, lanes 2-4). As 
expected (Hengartner et al. 1998), GST-CTD (C-termina1 domain) was phosphorylated 
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by both Srb 1 omyc9 and Kin28myc9 immunoprecipitates (lanes 6-8). GST -CTD kinase 
activity observed in the Kin28myc9 immunoprecipitate was not due to contaminating Srb 10 
because similar activity was recovered from an srbl0t1 strain (lane 8). These data 
demonstrate that the high MW Gcn4 kinase activity that we enriched for is due to Srb10, 
not Kin28. To further confirm the specificity of the kinase activity present in Srb10myc9 
immunoprecipitates, we evaluated the Gcn4 kinase activity of immunoprecipitates 
prepared from an srbl 0-3111-"c9 strain, which harbors an active-site mutant form of the 
SrblO kinase that is incorporated into the RNA polymerase II holoenzyme (Liao et al. 
1995). Although similar amounts of Srb protein were present in Srb 1 omyc9 and Srb 10-
3myc9 immunoprecipitates (Fig. 3B, lower panel), only the former phosphorylated Gcn4 
(Fig. 3B, upper panel). 
In our initial experiments to test the ability of SrbiO to phosphorylate Gcn4, we 
used a strain (Z689) that expressed HA-tagged Srb 11, the cyclin partner of Srb I 0. Anti-
HA immunoprecipitates from Z689 cells contained Gcn4 kinase activity similar to that 
shown in Fig. 3A (data not shown). e5S]methionine-labeled Gcn4, after pre-incubation 
with an Srb II HA immunoprecipitate, was ubiquitinated in the presence of purified Uba 1, 
Cdc34 and SCFCdc4(Fig. 3C, lane 4). This reaction was specific because it was dependent 
on all of the above components and ubiquitin (lanes 2, 5-8). Ubiquitination of Gcn4 by 
the Cdc34/SCpCdc4 pathway was also reconstituted with Gcn4 produced in E. coli (Fig. 
3D). The greater reaction efficiency observed in this experiment was most likely due to 
the use of SCF preparations containing Hrtl. Taken together, these results indicate that 
phosphorylation of Gcn4 by Srb 10 promoted its recognition and ubiquitination by 
scpCdc4. 
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Srbl 0 phosphorylates Gcn4 and regulates its stability in vivo 
To investigate the physiological relevance of our biochemical data, we first tested 
if Srb 10 influences the phosphorylation state of Gcn4 in vivo by evaluating the 
electrophoretic mobility of Gcn4myc9 immunoprecipitated from pulse-radiolabeled wild-
type and srbJO mutant cells. Gcn4 was phosphorylated in vivo in an SrblO-dependent 
manner as evidenced by a phosphatase-sensitive (Fig. 4A, right panel) MW upshift that 
was diminished in srbJO mutant cells (Fig. 4A, left panel). This, combined with our in 
vitro observations, strongly suggests that the Srb 10 CDK is a physiological Gcn4 kinase. 
If SrbiO targets Gcn4 for turnover by the SCFcctc4 pathway, we predicted that 
Gcn4 should be stabilized in srbJO mutants. To test this possibility, we carried out pulse-
chase experiments to measure the turnover rate of Gcn4myc9 in wild-type and srbl 0 
mutants. It is important to note that the tagged Gcn4 was expressed from the endogenous 
GCN4 locus, under the control of the native promoter. Consistent with previously 
published results (Kornitzer et al. 1994; Meimoun et al. 2000), Gcn4myc9 was rapidly 
degraded in wild-type cells, with a half-life of 2.5-5 min (Figs. 4B and 5B). In contrast, 
Gcn4 myc9 was moderately stabilized in both srbl 0-3 and srbl OL1 mutants with a half-life 
of I 0-12 min (Figs. 4B and 5B). Consistent with this difference in half-life, the steady-
state level of Gcn4myc9 is about two-fold higher in srbl 0 mutant cells compared to wild 
type (Fig. 4C). Careful examination of autoradiograms revealed that the 
phosphorylation-dependent upshifted form of Gcn4myc9 was strongly reduced, but not 
eliminated, in srbJO cells (Figs. 4B, 5A, and 5B). Furthermore, Gcn4myc9 was more 
effectively stabilized in cdc34'·' cells at the restrictive temperature (t112 > 20 min; Fig. 4D). 
We thus inferred that there might be additional protein kinases that can target Gcn4 for 
degradation via the Cdc34/SCFcctc4 pathway. 
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Both SrbJO and Pho85 contribute to Gcn4 turnover in vivo 
Meimoun et al. (2000) noted in their report that Gcn4 is not stabilized in an srbl0-
3 mutant. However, we reproducibly observed partial stabilization of Gcn4 in srbl 0 
mutants. Since Meimoun et al. performed their pulse-chase analyses with overexpressed 
derivatives of Gcn4, we evaluated whether overproduction influenced the apparent rate of 
Gcn4 degradation. To test this, we directly compared the rates of Gcn4myc9 degradation in 
strains that expressed GCN4myc9 from a GAL promoter with the strains that expressed 
GCN4myc9 from its own promoter. Indeed, when Gcn4myc9 was overproduced, its rate of 
degradation appeared very similar in wild-type and srbl0t1 cells (Fig. SA, top panels). At 
normal levels of expression, however, Gcn4 was clearly stabilized in an srbl0t1 mutant 
(Fig. SA, bottom panels). Immunoblotting confirmed that the steady-state levels of 
Gcn4myc9 were at least five-fold higher in GAL-driven GCN4111-"c9 strains compared with 
native-promoter-driven GCN4myc9 strains (data not shown). Interestingly, we also noticed 
a progressive, SRBJ 0-independent post-translational modification of Gcn4myc9 when it 
was overproduced (Fig. SA, arrowhead; note that Gcn4 expressed from its own promoter 
does not show the same extent of progressive modification in srbl Ot1 cells), suggesting 
that the overexpressed protein is more susceptible to a protein kinase that normally does 
not act (or acts poorly) upon endogenously expressed Gcn4. 
We evaluated Gcn4myc9 stability in several other CDK mutants in an attempt to 
address whether multiple CDKs play a redundant role in Gcn4 turnover. Gcn4myc9 
degradation was unaffected in ctkl t1 and a-factor arrested cells, suggesting neither Ctk 1, 
a CDK homolog that phosphorylates CTD, nor Cdc28 contributed to turnover (data not 
shown). However, we found that Gcn4myc9 was moderately stabilized in a pho85t1 mutant 
with a half-life of about 20 min (Fig. SB), similar to what was reported by Meimoun, et 
al. (2000). To test if SrblO and Pho8S contribute independently to Gcn4 turnover, we 
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tested Gcn4myc9 stability in an srbl011 pho8511 double mutant strain. As shown in Fig 5B, 
Gcn4myc9 was further stabilized in srbl011 pho8511 cells with a half-life of over 40 min, 
similar to what was observed in cdc34 '"cells at 3rC (Fig. 4D). Since srbl 0 and pho85 
mutations had an additive effect, we conclude that at least two CDKs (SrblO and Pho85) 
contribute to rapid Gcn4 turnover in vivo. 
Srbl 0-dependent degradation of Gcn4 is not regulated by amino acid starvation 
Since stabilization of Gcn4 under amino acid starvation conditions is achieved at 
least in part by the down regulation of Pho85 activity (Meimoun et al. 2000), we wanted 
to test if Srb 1 0-dependent degradation of Gcn4 was regulated in a similar fashion. To 
test this, we imposed amino acid starvation conditions by culturing cells in minimal 
medium lacking a specific amino acid that the cells were auxotrophic for and then 
measured Gcn4 stability under starved and unstarved conditions in wild-type, srbl 011, 
and pho8511 cells. Although Gcn4myc9 was significantly stabilized upon amino acid 
starvation with a half-life of about 20 min (Fig. 6A), it is further stabilized in srbl 011 cells 
with a half-life of about 40 min (Fig. 6B). Furthermore, Srb 1 0-dependent 
phosphorylation of Gcn4myc9 (as indicated by the MW shift) was not diminished upon 
starvation (Fig 6A, B), suggesting that it is not regulated by amino acid starvation. 
Whereas amino acid starvation significantly stabilized Gcn4"'Yc9 further in srbl011 cells, it 
only increased Gcn4myc9 half-life slightly in pho8511 cells (Fig. 6C). Taken together, these 
results suggest that Srb 10 is not involved in the starvation-regulated aspect of Gcn4 
turnover, and down-regulation of Pho85 is the primary means of stabilizing Gcn4 upon 
amino acid starvation. 
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CDK phosphorylation is required for rapid Gcn4 turnover in vivo 
The protein sequence of Gcn4 reveals five putative CDK phosphorylation sites 
(S(fP): S17, T61, T105, T165 and S218. Our analyses ofGcn4 ubiquitination in vitro 
and stability in vivo suggest that these sites may be important for rapid Gcn4 turnover. 
To test this possibility, we phosphorylated purified Gcn4 using Srb10myc9 
immunoprecipitates and subjected the in vitro phosphorylated Gcn4 to mass spectrometry 
analysis. All phosphopeptides that were recovered contained one of the five consensus 
S(fP sites. Moreover, direct sequencing confirmed that four of the consensus sites (S 17, 
T61 , Tl 05, and S218) were phosphorylated. The exact site of phosphorylation on Tl65-
containing peptides could not be determined, but was presumed to be T165. To analyze 
if any of these sites is important for Gcn4 turnover, we first mutated each of the five sites 
by site-directed mutagenesis, and produced mutant forms of Gcn4 protein by in vitro 
translation. We then tested the ability of the five single and a quintuple (3T2S) 
phosphorylation-site mutants of Gcn4 to serve as substrates for SCFcdc4-dependent 
ubiquitination in vitro. Although we did not observe a marked defect for any of the 
single-site mutants, ubiquitination of the 3T2S quintuple mutant was greatly diminished 
(Y. Chi and R. Deshaies, unpublished data). Based on our in vitro data, we constructed a 
strain in which the wild-type GCN4 locus was replaced with gcn4-3T2S"'.rc9 , and the 
stability of the encoded mutant protein was tested by pulse-chase analysis. As shown in 
Fig. 7B, Gcn4-3T2Smyc9 was very stable in vivo, and there was no appreciable 
degradation during the 40-min chase period. Noticeably, the mutant protein did not 
exhibit the characteristic MW shift caused by SrblO-dependent phosphorylation. 
The gcn4-3T2S111-"cY strain did not show any obvious morphology or growth defect 
compared with wild-type. Since we utilized a C-terminally myc9-tagged version of 
GCN4 for all of our in vivo studies, we were concerned that the myc9 tag might render 
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Gcn4 inactive. To test the activities of various Gcn4 derivatives in our strains, we 
employed a starvation plate assay similar to that described by (Natarajan et al. 1999). 
Cells were streaked on a control plate with normal leucine supplement and a plate with 
excess leucine, which causes isoleucine (lle) and valine (Val) starvation (Niederberger et 
al. 1981 ). This assay monitors Gcn4-dependent activation of Ile and Val biosynthetic 
genes. As shown in Fig. 7 A, all strains (tagged or untagged GCN4), except gcn4 deletion 
mutants, grew on -lie, -Val plates equally well as on control plates, suggesting that the 
myc9 tag did not diminish the function of Gcn4. Furthermore, normal growth of gcn4-
3T2sm.rc9 cells on the starvation plate suggests that CDK phosphorylation is not essential 
for Gcn4 function. 
SrblO phosphorylates Msn2 and influences its locahzation 
Microarray analysis of genome-wide gene expression in the srbl 0-3 mutant reveals 173 
genes whose expressions are up two-fold or more than wild-type, and a s ignificant 
fraction of these genes are involved in stress response and diauxic shift (Holstege et al. 
1998). Msn2 and Msn4 are two partially redundant zinc-finger transcription factors that 
activate expression of a suite of stress-response genes (Martinez-Pastor et al. 1996; 
Schmitt and McEntee 1996; Boy-Marcotte et al. 1998), including those induced in srbl 0-
3 cells. Based on our analysis of Gcn4 regulation, we hypothesized that Srb 10 might also 
directly repress the activities of transcription factors, including Msn2 and Msn4, by 
targeting them for degradation by the SCF pathway. To this end, we tested the ability of 
Msn2 to serve as a substrate for SrblO in vitro. Using an assay similar to that shown in 
Fig. 3A, we found Srb10 to be a potent kinase for recombinant GST-Msn2 (Fig. 8A, lane 
6). Furthermore, phosphorylated GST-Msn2 was efficiently ubiquitinated by SCFcdc4 
(data not shown). However, pulse-chase analysis revealed that Msn2myc9 was a stable 
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protein in wild-type cells with a half-life of more than 1 hr (data not shown). 
Interestingly, when pulsed-labeled at 2rc and chased under heat stress conditions 
(37°C), Msn2 was rapidly (within 5 min) phosphorylated in an SRBJO-dependent manner 
(Fig. 8B). Taken together, these data suggest that SrblO phosphorylates Msn2 in vivo in 
response to stress. However, Srb10-dependent phosphorylation did not appear to target 
Msn2 for degradation via the Cdc34/SCP:dc4 pathway. 
Recent evidence suggests that Msn2 and Msn4 are regulated by shuttling between 
the cytoplasm and the nucleus in response to environmental conditions. Under normal 
conditions, Msn2 and Msn4 are retained in the cytoplasm, presumably by a combination 
of active nuclear export and cytoplasmic anchorage (Gomer et al. 1998; Beck and Hall 
1999). To test if Srb l 0 influences the localization of Msn2/Msn4, we monitored Msn2 
localization in MSN2 111-""9 strains by indirect immunofluorescence. As expected, Msn2myc9 
was mostly cytoplasmic in wild-type cells under unstressed conditions (Fig.8C, panel a; 
Gomer et al. 1998). Interestingly, Msn2myc9 was localized to the nuc1eus in a sub-
population (15-30%) of unstressed srbl 0-3 cells (Fig. 8C, panel c) and srbl 011 cells (data 
not shown). Although we do not understand why Msn2 was mislocalized in only a 
fraction of srbl 011 cells, our results are consistent with the elevated expression of 
MSN2/MSN4-dependent genes in srbl0-3 cells as determined by microarray analysis of a 
population of cells (Holstege et al. 1998). 
Because Msn5 has been shown to be a nuc1ear exporter for Pho4 that has been 
phosphorylated by Pho85 (Kaffman et al. 1998), we next tested if Msn5 was also required 
for the export of Msn2. Strikingly, Msn2myc9 was concentrated in the nucleus in >90% of 
msn511 cells under normal conditions (Fig. 8C, panel b), suggesting that Msn5 is the 
primary export receptor for Msn2. 
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Discussion 
SCF ubiquitin ligases have been implicated in the regulation of multiple 
transcription factors, including 13-catenin, Gcn4, and Met4 (Deshaies 1999). Here, we 
provide four major lines of evidence that the SrblO CDK complex of the SRB/mediator 
module of the RNA polymerase II holoenzyme contributes to Gcn4 instability by 
phosphorylating Gcn4 and thereby targeting it to SCFcdc4 • First, a high MW SrblO-
containing complex was purified as the most prominent activity in yeast extract that 
sustains SCFcdc4-dependent ubiquitination of Gcn4. Second, immunopurified Srb 10 
phosphorylated recombinant Gcn4, thereby rendering it a substrate for recombinant 
scpCdc4 • Third, Gcn4 was phosphorylated in an SRBJO-dependent manner in vivo. 
Fourth, Gcn4 was partially stabilized in srbl 0 mutants. Taken together, our observations 
indicate that Gcn4 is a physiological target of SrblO, and raise the intriguing possibility 
that recruitment of SRB/mediator may limit how long a transcriptional regulatory protein 
can occupy a promoter. 
Regulation ofGcn4 by SrblO and Pho85 
During the course of our work, Meimoun et al (2000) reported that Pho85 is 
required for rapid turnover of Gcn4. Although they show that Gcn4 is phosphorylated in 
vitro by recombinant Pcll/Pho85, there is no direct evidence that this modification 
triggers its ubiquitination by SCFcdc4 • Thus, it remains possible that Pho85 influences 
both Gcn4 and Sic 1 (Nishizawa et al. 1998; Meimoun et al. 2000) degradation through an 
indirect effect on scpCdc4 activity. Nevertheless, we favor the hypothesis that both SrblO 
and Pho85 directly promote Gcn4 turnover, and that the kinases act independently to 
target Gcn4 degradation, based on the observation that Gcn4 was modestly stabilized in 
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pho85.1 and srbl0.1 cells, but strongly stabilized in pho85.1 srbl0.1 double mutants. Our 
observations coupled with those of Meimoun et al. suggest that it may be possible to 
generate more sophisticated regulatory controls by making the SCF-dependent turnover 
of a substrate require its phosphorylation by two or more kinases. Because distinct 
protein kinases can target different substrates to a single type of SCF complex (e.g. G 1-
CDK targets Sic I , whereas either Srb 10 or Pho85 targets Gcn4, to the SCFcdc4 complex), 
and because there are potentially 17 different types of SCF complexes and 120 prote in 
kinases in yeast, combinatorial interactions between these elements can potentially 
generate a staggering array of regulatory controls. 
Recent evidence suggests that amino acid starvation stabilizes Gcn4 through the 
negative regulation of Pho85-dependent phosphorylation (Meimoun et al. 2000). 
Interestingly, we found that Gcn4 was only moderately stabilized upon starvation and 
was further stabilized in srb10.1 cells. Moreover, SrblO-dependent phosphorylation of 
Gcn4 remained intact in amino acid-starved cells (Fig. 6A, B). This indicates that 
whereas Pho85 is down-regulated upon starvation, Srb 1 0-dependent degradation of Gcn4 
persists. It appears that Srb 10 and Pho85 contribute to SCFcdc4 -dependent degradation of 
Gcn4 in different ways, either by targeting different pools of Gcn4 or by responding to 
different cellular signals. 
If Srb 10 negatively regulates Gcn4 by promoting its turnover, one would expect 
to see increased expression of Gcn4 target genes in srbl 0 mutants. Although microarray 
analysis of genome-wide gene expression in the srbl 0-3 mutant reveals 173 genes whose 
expressions are up two-fold or more compared to wild-type (Holstege et al. 1998), only 
two of these are potential Gcn4 targets. This suggests that srbl 0 mutation does not lead 
to global derepression of Gcn4 target genes under normal growth conditions. We provide 
the following possible reasons to explain the microarray data. First, stabilization of Gcn4 
in srbl 0 mutants only leads to ~ 1.5-2 fold increase in the steady state level of Gcn4 (Fig. 
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4C). Compensatory regulatory mechanisms, such as redundant kinases that promote 
Gcn4 turnover and the well-characterized Gcn4 translational controls, may serve to limit 
the accumulation of Gcn4 in srbl 0 cells. The former possibility is supported by the 
observation that the 3T2S mutations have a greater effect on Gcn4 stability than the 
pho85 srblO double disruption (compare Fig. 5B, Fig. 7B). Second, SrblO may have 
self-canceling positive and negative effects on Gcn4. It is possible that phosphorylation 
of Gcn4 by Srb 10 stimulates its activity while also promoting its turnover. If so, the loss 
of SrblO-dependent phosphorylation of Gcn4 may not only stabilize the protein but also 
decrease its potency as a transcriptional activator. Third, pleiotropic effects of srbl 0 
mutation, such as derepression of the stress response genes (Holstege et al. 1998) and 
slow growth, may indirectly alter the expression profile of Gcn4 target genes. Despite 
the absence of major change in the transcriptional output of Gcn4 in srbl 0 mutants, it is 
evident that Srb 10 negatively regulates Gcn4 by promoting its rapid turnover. 
Regulation of Msn2 and Msn4 by SrbJO 
The transcriptional activities of the partially redundant Msn2 and Msn4 proteins 
are tightly regulated. In resting cells these factors are inactive, whereas in stressed cells 
they promote transcription of a large suite of genes (Martinez-Pastor et al. 1996; Schmitt 
and McEntee 1996; Boy-Marcotte et al. 1998). Srb 10 is implicated in the regulation of 
Msn2/Msn4, in that multiple transcriptional targets of these proteins are induced in 
srbl 0-3 cells (Holstege et al. 1998). Msn2 was phosphorylated by Srb 10 in vitro, and the 
phosphorylation state of Msn2 was modulated by Srb 10 in vivo (Fig. 8A, B). In contrast 
to Gcn4, however, Msn2 was stable in resting or stressed cells, regardless of whether it 
was localized to the cytoplasm or nucleus (data not shown). 
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Activation of Msn2 in stressed cells is linked to its translocation from the 
cytoplasm to the nucleus (Gomer et al. 1998). Whereas Msn2 is exclusively cytoplasmic 
in resting wild type cells, Msn2 was primarily nuclear in 15-30% of srbJO cells (Fig. 8C). 
Although our data show that SRBJ 0 can influence Msn2 localization, other factors, 
including the TOR and cAMP-dependent protein kinases, govern the nucleocytoplasmic 
shuttling of Msn2 in stressed cells (Gomer et al. 1998; Beck and Hall 1999), and 
regulated trafficking of Msn2 still occurred properly in the majority of srblO cells (data 
not shown). The underlying basis for the heterogeneity of srbl 0 cell populations is 
unclear. Perhaps the majority of srbl0!1 cells adapt to chronic Msn activity in the 
nucleus by inducing factors that partially bypass SrblO's role in Msn2 export. Regardless 
of the exact relationship between stress, Msn2/Msn4, and Srb I 0, the most parsimonious 
hypothesis is that the global induction of Msn target genes in srbl 0-3 cells (Holstege et 
al. 1998) results, at least in part, from failure to properly phosphorylate and thereby 
promote Msn5-dependent export of Msn2/Msn4 from the nucleus. Mapping and 
mutation of SrblO phosphorylation sites in Msn2 wiii be needed to vigorously establish a 
direct role for SrblO in the nuclear export of Msn2. 
Implications for negative regulation of transcription by SRB/mediator: beyond CTD 
phosphmylation 
The Srb 1 0/Srb 11 CDK/cyclin pair is part of a heterotetrameric module, which 
associates with the multiprotein complex termed "SRB/mediator" (Myer and Young 
1998). Current models suggest that the Srb 10 module functions through CTD of RNA 
polymerase II, in part by controlling its phosphorylation (Hengartner et al. 1998). Both 
genetic and microarray analyses indicate that Srb 10 serves as a negative effector of 
specific transcriptional programs (Carlson 1997; Ho1stege et al. 1998). These 
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observations pose a key question: how does Srb 10 activity selectively repress the 
expression of a small subset of the genome? Biochemical studies revealed that 
phosphorylation of CTD by SrbtO blocked the recruitment of RNA polymerase 
holoenzyme to promoter DNA (Hengartner et al. 1998). It was postulated that gene-
specific control by Srb lO might be mediated by promoter-bound factors that influence 
whether or not Srb 1 0/Srb 11 phosphorylates CTD before a promoter-bound preinitiation 
complex is formed. 
An expanded view for how Srb I 0 negatively regulates transcription of selected 
genes is supported by our work. Specifically, we propose that Srb 10 directly 
phosphorylates transcription factors, thereby altering their activity. This provides a 
simple and logical explanation for how Srb 10 mediates gene-specific transcriptional 
regulation. Interestingly, the exact mechanism of regulation appears to differ for 
different transcription factors. Whereas SrblO targets Gcn4 for scpCdc4-dependent 
degradation, it appears to down-regulate Msn2 activity by promoting nuclear exclusion 
(although the exact manner in which this occurs remains to be determined). In support of 
a direct role for Srb 10 in the regulation of transcription factors, phosphorylation of the 
S699 residue of Gal4 by Srb 10 was recently shown to be essential for Ga14-dependent 
induction of GAL genes (Hirst et al. 1999). Coupled with phosphorylation of the CTD, 
direct phosphorylation of specific transcription factors by Srb 10 might potentiate its 
inhibitory effect on transcription and help focus its repressive activity upon specific 
promoters. 
An interesting idea that emerges from ours and other studies is that direct negative 
regulation of transcriptional activators by SrbtO may be confined to the vicinity of 
promoters to limit the lifetime of transcription factors that are actively engaged in 
promoting transcription. We propose that Srb 10 comprises a "timer" that constitutively 
targets promoter-bound Gcn4 for degradation to limit the number of transcripts that a 
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DNA-bound molecule of Gcn4 can promote. Intriguingly, analysis of a set of synthetic 
transcriptional activators revealed an inverse relationship between their potency and their 
stability, suggesting that the degradation of transcription factors may be mechanistically 
coupled to their ability to promote assembly of active transcriptional complexes on 
promoter DNA (Molinari et al. 1999). Thus, spatially restricted activation of 
transcription factor proteolysis may be a general regulatory theme. Note that a related 
argument can also be advanced for Msn2 and Msn4, whereby SrblO-dependent 
phosphorylation initiates the nuclear export of Msn molecules located at promoter 
elements. Although our studies highlight roles for Srb 10 in the control of Gcn4 stability 
and Msn2 export, it is possible that Srb I 0 modulates other aspects of transcription factor 
activity in a spatially restricted manner. It will be interesting to see if the mammalian 
homolog of SrbiO likewise mobilizes diverse regulatory strategies to enable tight 
regulation of gene expression. 
Materials and methods 
Yeast strains 
The yeast strains used in this study are listed in Table I . All YC strains were 
derived from Z719, Z690, and Z687 (Liao et al. 1995). Yeast cells were cultured in 
standard rich or synthetic medium supplemented with 2% dextrose, raffinose, or 
galactose as described (Sherman 1991). The GCN4locus was modified to encode Gcn4 
tagged with three copies of the HA epitope (HA3) at its C-terminus as described 
(Schneider et al. 1995), and a gcn4 deletion strain (gcn4: :HA3) was generated using a 
similar scheme. The GCN4, SRBJO, srbJ0-3, KJN28 and MSN2loci were modified to 
encode proteins tagged with nine copies of the myc epitope (myc9) at their C-termini as 
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described (Seol et al. 1999). GAL-GCN4 alleles were generated by replacement of the 
entire GCN4 promoter region with a PCR fragment containing URAJ and GALl, 10 
promoter sequences. cdc34'' strains were constructed by homologous recombination 
using a plasmid carrying cdc34-2 (Kornitzer et al. 1994). The gcn4, pho85 and msn5 
deletion strains were generated by PCR-based one-step replacement. Deletion alleles 
were confirmed by scoring mutant phenotypes and by PCR. To generate the gcn4-
3T2S"I.'c9 strain, sequences spanning the five SP(TP sites within GCN4111-""9 were first 
replaced by URAJ. The resulting GCN4111-""9 ::URA3 strain was subsequently transformed 
with a gcn4-3T2S fragment that also contained adjacent 5 ' untranslated sequences. 
Transformants were cultured in YPD for 6-10 hours prior to plating on 5-fluoroorotic 
acid (5-FOA) medium. 5-FOA resistant transformants were screened by PCR and 
confirmed by sequencing. All strains derived from Z719, Z690 or Z687 were constructed 
either by direct transformation using lithium acetate method or by genetic cross. Details 
of the strain constructions or oligonucleotide sequences are available upon request. 
Fractionation of yeast extracts 
Whole cell or DEAE Sepharose FF (Amersham Pharmacia) fractions of yeast 
extracts from G 1 cyclin-depleted RJD885 or RJD893 cells were prepared as described 
(Verma et al. 1997b) with the following modifications. After the frozen cell powder was 
thawed in Buffer93 (B93), saturated (100%) ammonium sulfate solution was added 
slowly to a final concentration of 10% to allow further extraction of proteins. To 
concentrate fractionated proteins prior to assay, the flow-through and 0.15-0.25 M NaCl 
eluate of the DEAE Sepharose column were concentrated (to ~30 mg/ml) using Ultrafree-
15 centrifugal filter (Biomax- IOK, Millipore) and dialyzed against B93. 
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To resolve Gcn4 kinase and ubiquitination activities, RJD893 whole ce11 extract 
(WCE) was first fractionated by ammonium sulfate precipitation. The 0-35% and the 45-
60% cuts were resuspended in CWB (25 mM HEPES [pH7.6], 25 mM NaCl and I mM 
DTT) and applied to a DEAE Sepharose column. The 0.25 M eluate from each DEAE 
fractionation was concentrated to 10-I5 mg/ml and dialyzed against B93. The 0.25 M 
DEAE eluate from the 0-35% ammonium sulfate cut contained Gcn4 kinase activity, 
whereas that from the 45-60% cut contained Gcn4 ubiquitination activity (when 
supplemented with the kinase fraction plus Cdc34). For assays shown in Fig. 2C, the 
dialyzed 0-35% ammonium sulfate cut was used directly without further purification. 
To partially purify the Gcn4 kinase, we grew RJD48 1 cells in YPD to late log 
phase [optical density at 600 nm (OD600)=2.5-3] and harvested and lysed them as 
described (Verma et al. I997b ). WCE (-1000 mg protein) was first fractionated by 
ammonium sulfate precipitation, and the 0-40% cut (-I50 mg protein) was resuspended 
in CWB and loaded onto a I 0-ml SP Sepharose FF (Amersham Pharmacia) column. The 
column was washed with 30 ml CWB and eluted with a 100-500 mM NaCl gradient. 
Fractions containing the peak activity (as measured by kinase and ubiquitination assays, 
see below) were pooled (-7 mg protein), diluted in CWB and applied to 2 ml of 
glutathione agarose (Sigma) previously loaded with -4 mg GST-Gcn4. The affinity 
column was washed with 5 ml CWB +100 mM NaCl and eluted with 4 ml CWB +400 
mM NaCl. The eluate was concentrated to 200 ~-tl (-300 j..tg protein) and 50 ~-tl was 
loaded onto a 2.4 ml Superdex200 column (Amersham Pharmacia) equilibrated with 
CWB +500 mM NaCI. 50 ~-tl fractions were collected and 2 ~-tl of each fraction was used 
in the activity assays. 
Preparation of assay substrates 
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GCN4 and SICJ were transcribed from EcoRI-linearized YEp88-GCN4 and 
RDB445 by SP6 and T7 polymerase, respectively. GCN4-HA transcription template was 
generated by PCR using a 5' oligonucleotide containing a T7 RNA polymerase promoter 
(Verma et al. 1997b) and a 3' oligonucleotide containing sequences that encode the HA 
epitope. All mRNAs were translated in rabbit reticulocyte lysates according to 
manufacturer's instructions (Promega). For ubiquitination assays, in vitro-translated 
Gcn4 was partially purified by batch chromatography on DEAE resin as described for 
Sicl (Verma et al. 1997a). The 100-400 mM NaCl DEAE eluate containing Gcn4 was 
heated at 65°C for 5 min to destroy a non-specific Gcn4 kinase activity present in 
reticulocyte lysates (brief heating at up to 90°C did not significantly compromise the 
ability of Gcn4 to serve as a ubiquitination substrate). The eluate was then centrifuged at 
10,000 g for 5 min and the supernatant was exchanged into 30 mM Tris-HCl (pH7.5), 50 
mM potassium acetate and 1 mM DTT by three cycles of dilution and concentration to 
the original volume in a Centricon-10 (Amicon). Recombinant Gcn4 was also expressed 
in E. coli and purified as described (Kim et al. 1994). GST, GST-Gcn4, and GST-Msn2 
were expressed in BL21 (DE3) containing pLyS, and were purified by glutathione affinity 
chromatography. GST-CTD was expressed and purified as described (Thompson et al. 
1993). 
lmmunoprecipitations, kinase assays and immunoblots 
Active protein kinases were isolated from yeast strains in which the relevant 
genes were modified to encode proteins with a myc9 epitope at the C-terminus. Cells 
were grown to late log phase (OD600 2.5-3) and whole cell extracts were prepared as 
described above. All purification procedures were performed on ice or at 4 oc. 
Typically, cell extract (200-300 f-ll of 30-40 mg/ml) was diluted three fold with Buffer B 
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(30 mM Tris-HCl [pH7.5], 6% ammonium sulfate, 1 mM EDTA, 1 mM DIT, 0.02% 
Triton X-100 and 0.5 mM PMSF), and pre-incubated with 15 f!l protein A beads for I hr. 
After brief centrifugation, the supernatant was incubated with 1 f!l of anti-myc 
monoclonal antibody 9E1 0 ascites fluid for 2 hrs and then 10-15 f!l of protein A beads for 
additional 1-2 hrs. The protein A beads were washed three times with Buffer B and once 
with kinase assay buffer (KAB: 30 mM Tris-HCl [pH 7.5], 10 mM MgC12, 10 mM NaCl, 
1 mM DTT and 0.02% Triton X-100). 
32P kinase assays were performed by incubating immobilized kinase with 1 f!g 
substrate (Gcn4, GST, GST-CTD or GST-Msn2) in a 10 f!l reaction containing KAB, 0.5 
f!l y-32P-ATP ( 4500 Ci/mmol), and 50 f!M A TP at 22°C for 1 hr with occasional mixing. 
The reaction was briefly centrifuged and the supernatant was either used immediately as 
substrate for the ubiquitination reactions (Figs. 3D) or mixed with Laemmeli sample 
buffer, boiled for 3 min, resolved by SDS-PAGE and visualized by autoradiography. For 
e5S]methionine-labeled Gcn4 substrates, kinase assays (Figs. 1 B and 3C) were carried 
out for 30 min at 25°C in KAB supplemented with A TP regenerating system. 
Immunoblotting was performed with either monoclonal 9E10 ascites fluid 
(1 :2000 dilution) or affinity-purified anti-Cdc28 polyclonal antibody. Blots were 
visualized using horseradish peroxidase-conjugated secondary antibodies and a 
chemiluminescence (ECL+) kit (Amersham). For experiment in Fig. 4C, blots were 
scanned and quantitated using the STORM system (Molecular Dynamics). 
Ubiquitination assays 
Ubiquitination reactions in yeast extracts (Verma et al. 1997a) or with purified 
components (Feldman et al. 1997; Seol et al. 1999) were carried out essentially as 
described. Two forms or SCFcdc4 were used during the course of this study: a triple 
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infection complex (Skp1/Cdc53PyHA/Cdc4PyHA) and a quadruple infection complex 
(Hrt1/Skp1/Cdc53/Cdc4PyHA), both of which were expressed in baculovirus-infected Sf9 
insect cells and purified by binding to anti-polyoma (a-Py)-conjugated protein A beads 
and eluted using Py peptide as described (Seol et al. 1999). Approximately 100-150 ng 
of scpcctc4 as estimated by Coommassie-stained gels was used in each reaction. 
Reactions were incubated at 2SOC for 1 hr, terminated by addition of Laemmeli sample 
buffer, and evaluated by SDS-PAGE and autoradiography. 
Pulse-chase experiments 
GCN4111"'9 , MSN2111~''9 , and untagged control cells were grown overnight in SD 
+leucine +histidine + uracil at 30°C to mid-log phase (OD600 -0.5). Approximately 3 x 
108 cells were harvested and concentrated by centrifugation into 3 ml of the same 
medium. Cells were pulse-labeled for 5 min with 500 f.A.Ci of Tran35Slabel ( 1175 
Ci/mmol, ICN), then chased in the same medium containing 1 mM ammonium sulfate, 
5mM methionine and 1mM cysteine. For cdc34-2 mutants, cells were shifted to 3rc for 
1 hr before labeling. At various times of the chase, 0.5 ml of the culture was removed 
and diluted immediately into 1.5 ml cold stop buffer (50 mM Tris-HCl [pH7.5], 50 mM 
NaF and 0.1 % NaN3). Cells were centrifuged briefly and cell pellets were frozen in 
liquid nitrogen (and stored at -80°C if necessary). The cell pellets were then each 
supplemented with I 00 f.A.l of 0.5 mm glass beads and I 00 f.A.llysis buffer (30 mM Tris-
HCl [pH7.5], 0.5% SDS, 6% ammonium sulfate, 1 mM EDTA, 1 mM DTT and 0 .5 mM 
PMSF), vortexed for 2 s, and boiled for 3 min. The samples were cooled briefly, 
vortexed for 2 min, boiled again for 2 min and vortexed again for I min. Samples were 
then centrifuged at 10,000 g for 10 min, and the supernatant was diluted five-fold with 
Triton buffer (30 mM Tris-HCl [pH7.5], 1% Triton X-100, 1 mM DTT and 1 mM PMSF) 
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and immunoprecipitated with 9E 10 antibody and protein A beads. The protein A beads 
were washed three times with Buffer B, aspirated to dryness, and mixed with 2X 
Laemmeli buffer. Samples were boiled for 3 min prior to being evaluated by SDS-PAGE 
followed by autoradiography and Phosphorlmager (Molecular Dynamics) analysis. 
ES-MS Analysis of phosphorylated Gcn4 
Phospho-Gcn4 (70 pmol) was digested with modified trypsin (Promega) for 6 
hours at 3rC and then subjected to multi-dimensional phosphopeptide analysis by 
ESMS (Verma et al. 1997c). Briefly, phosphopeptides were detected by online LC-
ESMS. The flow from the column was split with 95% going to a fraction collector and 
5% to the mass spectrometer. The mass spectrometer is optimized to produce and 
detect CID generated m/z 79 (P03-) product ions, which are highly specific for 
phosphorylated peptides (Huddleston et al. 1993). The MS is operated in a single ion-
monitoring mode for enhanced sensitivity. Phosphopeptide-containing HPLC 
fractions (containing m/z 79 ions) were then analyzed by negative-ion 
nanoelectrospray using precursor ion scans to distinguish phosphopeptides from 
unmodified peptides, and determine their mass (Carr et al. 1996). Candidate 
phosphopeptides were sequenced by tandem mass spectrometry using with nanoES 
(Carr et al. 1996) or on LC-ES MS/MS (Zhang et al. 1998). Phosphorylation site 
stoichiometry was determined by measuring the ratio of phosphorylated to 
nonphosphorylated peptide in the positive ion ES spectrum. Positive ion spectra for 
each phosphorylated and nonphosphorylated peptide were extracted and summed from 
a full scan LC-MS analysis of 18 pmol of Gcn4 tryptic digest. 
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Immunofluorescence 
Cells were growing overnight in 30 ml YPD at 2rc to mid-log phase (OD600 
~0.5). 4 ml of cells were then removed and fixed with 4.5% formaldehyde at room 
temperature for 1 hr. Indirect immunofluorescence was carried out essentially as 
described (Pringle et al. 1991) using 9E 10 (1 :3000) as primary antibodies and 
fluorescein-conjugated-goat-anti-mouse antibodies (1 :3000) as secondary antibodies. 
Fujichrome Provia 400 slide film was used to record data images on a Zeiss Axioskop 
microscope. 
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Figure 1. Gcn4 ubiquitination in yeast extracts requires SCF components and a protein 
kinase activity other than Cdc28. 
(A) e5S]methionine-labeled Gcn4 (lanes 1-4) or Sicl (lanes 5-8) synthesized by in vitro 
translation were incubated with G 1-cyclin depleted yeast whole cell extracts from 
RJD885 strain in the absence (lane 2 ,6) or presence (lane 3 ,7) of purified GST -Cln2. 
Ubal, Cdc34 and SCF activities were supplied by the yeast extracts. Lanes 1 and 5 
contained only input substrates. Methylated ubiquitin (me-ubiquitin) was used instead of 
wild-type ubiquitin in lanes 4 and 8. Encircled Prefers to phosphorylated forms of Sic I 
and Gcn4. All samples in panels A-C were evaluated by SDS-PAGE followed by 
autoradiography. 
(B) e5S]methionine-labeled Gcn4HA translation product was phosphorylated by DEAE 
flow-through fraction of RJD885 whole cell extract (see Materials and Methods). An 
aliquot of the reaction was immunoprecipitated using 12CA5 antibody and mock treated 
(lane 2) or treated with calf intestinal alkaline phosphatase (ClAP) in the absence (lane 3) 
or presence (lane 4) of phosphate inhibitor as described (Verma et al. 1997a). 
Immunoprecipitated input Gcn4HA is shown in lane 1. 
(C) Ubiquitination of Gcn4 in fractionated yeast extracts from a cdc41s strain (RJD 893). 
Extract fractions lacking Cdc34 but supplying either SCF components or a kinase activity 
were used (see Materials and Methods). A complete reaction (lane 6) included a kinase 
fraction ( -10 f,tg) , a ubiquitination fraction (-15 f,tg) , Cdc34 (1 00 ng) and insect cell 
lysate containing baculovirus-expressed Cdc4 (-4 f,tg total protein, Verma et al. 1997a). 
In lanes 1-S,one or more of the above components was omitted, as indicated. Insect cell 
lysate containing baculovirus-expressed Cdc28 was used as specificity control (lane 7) 
for the Cdc4 lysate. 
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Figure 2. Identification of SrblO as the protein kinase that promotes Gcn4 ubiquitination 
in yeast extracts. 
(A) Purification scheme (see Materials and Methods for details). 
(B) The indicated fractions from a Superdex 200 column were evaluated for both protein 
kinase activity using Gcn4 expressed in E. coli (bottom panel) and ubiquitination-
promoting activity using [35S]methionine-labeled Gcn4 (top panel). Each ubiquitination 
reaction included -lOOng of "triple infection" scpc<tc4 (see Materials and Methods). The 
bracket highlights the peak ubiquitination-promoting activities (fractions 3 ,5). 
(C) Ubiquitination reactions were carried out with e5S]methionine-labeled Gcn4 (lane 1) 
in the presence of "triple infection" scpcdc4 and a fraction of yeast extract that was 
enriched for Gcn4 kinase activity (see Materials and Methods). Varying amounts (5, 10 
and 20 ~-tg) of "kinase fraction" prepared from an SRBJO (Z719, lanes 2-4) or an srblOL1 
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Figure 3. SrblO directly phosphorylates Gcn4, and targets it for SCFcctc4-dependent 
ubiquitination. 
(A) Immunoprecipitates from SRB10111-"'"9 strain YC6 (lanes 2, 6), KIN28111-"c9 strains YCI5 
(lanes 3 ,7) and YC 16 (lanes 4 ,8) and untagged strain YC I (lanes 1 ,5) were assayed for 
kinase activity using, as substrate, Gcn4 (lanes 1-4) or GST-CTD (lanes 5-8) purified 
from E. coli. Reactions were evaluated by SDS-PAGE and autoradiography. 
(B) Same as (A), except immunoprecipitates from SRB1 0111-"'"9 strain YC 17 (lane 2) and 
srb1 0-3111Y'"9 strain YC7 (lane 4) were compared (top panel). Untagged strains Z719 (lane 
1) and Z690 (lane 3) were used as controls. Antigen levels were monitored by 
immunoblotting duplicate immunoprecipitates with 9E 10 antibody (bottom panel). 
(C) SrblO protein kinase activity was immunoprecipitated from Z689 (SRB1 jHA) with 
12CA5 antibody. This immunoprecipitate had strong Gcn4 kinase activity similar to 
SRB10111-"c9 strains shown in (A) and (B) as judged by 32P kinase assays (data not shown). 
The ubiquitination assay was carried out by first incubating [35S]methionine-labeled Gcn4 
with Srbll HA bound to protein A beads. An aliquot of the supernatant was used in the 
subsequent ubiquitination reactions (lanes 3 -8). Immunoprecipitates from untagged 
strain Z719 were used as controls (lanes 1 ,2). Ubiquitination reactions were either 
supplemented with a complete set of components (lanes 2,4) including SCFcdc4 (triple 
infection) or a subset of components in which the factor indicated above each lane was 
omitted (lanes 5-8). 
(D) Gcn4 purified from E. coli was first phosphorylated in a kinase assay as shown in 
panel B, lane 2. 32P-labeled Gcn4 was then added to ubiquitination reactions that were 
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Figure 4. Srb 10 phosphorylates Gcn4 and regulates its stability in vivo. 
(A) (Left panel) Cells from strains carrying untagged GCN4 (Z719, lane 1; Z687, lane 3; 
Z690, lane 5) or GCN4mrcY (YC19, lane 2; YC21, lane 4; YC45, lane 6) were pulse-
labeled for 5 min (without chase) in SD medium containing Tran35Slabel. Celllysates 
were immunoprecipitated using 9E10 antibody and evaluated by SDS-PAGE and 
autoradiography as described in Materials and Methods. (Right panel) Same as left panel, 
except the immunoprecipitated samples were either mock-treated (lanes 7,9) or treated 
(lanes 8,10) with 2 U ClAP at 3rc for 30 min. 
(Band D) Pulse-chase analysis of Gcn4myc9 stability in SRB10 (YC19), srb10-3 (YC45), 
CDC34 (YC19) and cdc34'" (YC35) cells. Quantitations of the experiments are shown on 
the right. The experiment in D was performed at 37°C. 
(C) SRB10 (Z719, lane 1; YC19, lanes 2,3,6,7), srb10-3 (YC45, lanes 4,5), or srb1011 
(YC2l, lanes 8,9) cells were cultured as described for the pulse-chase experiments, 
harvested and lysed by boiling in SDS-containing buffer. Equal amounts (-50 !J.g) of cell 
lysates were analyzed by immunoblotting using 9E 10 (top panels) and anti-Cdc28 
(bottom panels) antibodies. Each sample (except the untagged control) was run in 
duplicate lanes, and lanes 1-5 and lanes 6-9 are from separate experiments. Bands were 
quantitated, and Gcn4 signals were normalized against Cdc28. Compared to wild-type, 
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Figure 5. Both Srb I 0 and Pho85 contribute to Gcn4 turnover in vivo. 
(A) Gcn4myc9 stability under normal and overproduced conditions. Wild-type (YC I9, 
YC23) and srbl0i1 (YC2I, YC24) cells grown in YP-raffinose medium were either 
transferred to synthetic galactose medium (top two panels) or synthetic dextrose medium 
(bottom two panels) for I hr prior to being subjected to pulse-chase analysis as described 
for Figure 4A. Quantitation of the results is shown on the right. The arrowhead denotes a 
post-translationally modified form of Gcn4myc9 that appeared rapidly in SRBJ 0 cells, but 
was only slowly generated in srbl0i1 strains. Note that the biphasic degradation observed 
for GAL-GCN4111Y"9 strains was likely due to the carry-over synthesis of Gcn4"'Y09 during 
the first 5 min of chase. 
(B) Gcn4 stability in wild-type (YC 19), srbl 011 (YC21 ), pho85 i1 (YC59) and 
srbl0i1 pho85i1 (YC61) cells was evaluated by pulse-chase analysis (see Fig. 4A legend). 
Quantitation of experiment is shown on the right. In two independent experiments, the 
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Figure 6. Srb 1 0-dependent degradation of Gcn4 is not regulated by amino acid 
starvation. 
(A) SRBJ 0 (YC 19) cells were grown to mid-log phase and transferred to either SO 
+leucine +histidine+ uracil (-starvation) or SD -leucine +histidine + uracil (+starvation) 
medium. Cells were cultured for 15 min and pulse chase analysis was carried out as 
described in Materials and Methods. Starving cells for 30 or 60 min resulted in similar 
magnitude of stabilization of Gcn4 (data not shown). Half-life of Gcn4 (t1/2) was 
determined from quantitation of the data using phosphorimager. 
(B) Same as (A), except SRBJO (YC 19, top panel) and srblOiJ. (YC21, bottom panel) cells 
were assayed for Gcn4 stability in SO -leucine +histidine+ uracil (+starvation) only. 
(C) Same as (A), except srblOiJ. (YC21, top panels) cells andpho85iJ. (YC59, bottom 






















Figure 7. CDK phosphorylation is not essential for Gcn4 activity, but is required for its 
rapid degradation in vivo. 
(A) Strains with the indicated genotypes were grown on SD +leu (-0.23 mM) +his+ ura 
medium (control) and the same medium supplemented with 40 mM leucine (-lle, -Val) to 
induce starvation for isoleucine and valine. Plates were photographed after incubation at 
30°C for 3 days. Top row of panels show wild-type strain (Z719) and mutant strains 
srblO.t1 (Z687), srbl0-3 (Z690) and gcn4::HA3 (YC25). Bottom row of panels show 
strains containing myc9-tagged GCN4 alleles (YC19, YC21, YC45, YC57 and YC94). 
(B) Pulse-chase analysis (see Fig. 4A legend) of Gcn4"'Yc9 stability in wild-type (YC 19) 













Heat shock - - ++ - - + + 




myc9 . sn ...,. ~ - - ~~-. 
fj f.j 
. " ' f 
·. ~ ·j. ·~·.0:. 
-GST 
" . . ~ .. ~·· ;q ':'t 
12345678 
WT msn5 L1 srb1 0-3 
128 
Figure 8. Msn2 is phosphorylated in an SrblO-dependent manner in vitro and in vivo, 
and its localization is influenced by Srb 10. 
(A) Kinase assays were carried out with purified GST (lanes 1 ,2), GST-Gcn4 (lanes 3,4), 
and GST-Msn2 (lanes 5,6) using immunoprecipitates from SRB10111-""9 strain (YC17, lanes 
2 ,4,6) and srb1 0-3111-"c9 strain (YC7, lanes 1,3 ,5) as described in Fig. 3A. 
(B) Cells from MSN2 111 ''" 9 (YC84, lanes 2-4) and MSN2 111-""9 srb10-3 (YC124, lanes 6-8) 
strains grown at 2rc were pulse-labeled with Tran35Slabe1 at 2rc for 5 min, and chased 
at 37°C for 5 min. Aliquots (1/3 before the heat shock and 2/3 after the heat shock) of 
the cultures were subjected to immunoprecipitation with 9E 10 antibody. 
Immunoprecipitates from the heat shock samples were divided and either mock-treated 
(lane 3 ,7) or treated (lanes 4 ,8) with 2 U ClAP for 30 min at 3rC. Untagged strains 
Z719 (lane 1) and Z690 (lane 5) were used as controls. 
(C) Localization of Msn2myc9 in wild-type (YC84,a), msn5.t1 (YCI07, b), and srb10-3 
(YC 124, c) cells was evaluated under resting conditions by indirect immunofluorescence 
with 9E 10 antibody. DAPI was used to stain cell nuclei. An srbl 0-3 strain containing 
untagged MSN2 (Z690) was used as control (d). 
129 
References 
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J.W., and Elledge, S.J. 1996. 
SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a 
novel motif, the F-box. Ce/186: 263-274. 
Beck, T., and Hall, M.N. 1999. The TOR signalling pathway controls nuclear localization 
of nutrient-regulated transcription factors. Nature 402: 689-692. 
Boy-Marcotte, E., Perrot, M., Bussereau, F., Boucherie, H., and Jacquet, M. 1998. Msn2p 
and Msn4p control a large number of genes induced at the diauxic transition which are 
repressed by cyclic AMP in Saccharomyces cerevisiae. 1 . Bacteriol. 180: 1044- 1052. 
Carlson, M. 1997. Genetics of transcriptional regulation in yeast: connections to the RNA 
polymerase II CTD. Annu. Rev. Cell Dev. Bioi. 13: 1-23. 
Carr, S.A., Huddleston, M.J., and Annan, R.S. 1996. Selective detection and sequencing 
of phosphopeptides at the femtomole level by mass spectrometry. Anal. Biochem. 239: 
180-192. 
Ciechanover, A., Orian, A., and Schwartz, A.L. 2000. Ubiquitin-mediated proteolys is: 
biological regulation via destruction. Bioessays 22: 442-451. 
Deshaies, R.J. 1999. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell 
Dev. Bioi. 15: 435-467. 
Drury, L.S., Perkins, G., and Diffley, J.F. 1997. The Cdc4/34/53 pathway targets Cdc6p 
for proteolysis in budding yeast. EMBO 1. 16: 5966-5976. 
Elsasser, S., Chi, Y., Yang, P., and Campbell, J.L. 1999. Phosphorylation controls timing 
of Cdc6p destruction: A biochemical analysis. Mol. Bioi. Cel/10: 3263-3277. 
Feldman, R.M., Correll, C.C., Kaplan, K.B., and Deshaies, R.J. 1997. A complex of 
Cdc4p, Skplp, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK 
inhibitor Siclp. Cel/91: 221-230. 
Gomer, W., Durchschlag, E., Martinez-Pastor, M.T., Estruch, F., Ammerer, G., 
Hamilton, B., Ruis, H., and Schuller, C. 1998. Nuclear localization of the C2H2 zinc 
finger protein Msn2p is regulated by stress and protein kinase A activity. Genes Dev. 12: 
586-597. 
130 
Henchoz, S., Chi, Y., Catarin, B., Herskowitz, I. , Deshaies, R.J., and Peter, M. 1997. 
Phosphorylation- and ubiquitin-dependent degradation of the cyclin- dependent kinase 
inhibitor Farl pin budding yeast. Genes Dev. 11: 3046-3060. 
Hengartner, C.J., Myer, V.E., Liao, S.M., Wilson, C.J., Koh, S.S., and Young, R.A. 1998. 
Temporal regulation of RNA polymerase II by SrblO and Kin28 cyclin-dependent 
kinases. Mol. Cel/2: 43-53. 
Hinnebusch, A.G. 1992. General and pathway-specific regulatory mechanisms 
controlling the synthesis of amino acid biosynthetic enzymes in Saccharomyces 
cerevisiae. In The molecular and cellular biology of the yeast Saccharomyces: gene 
expression (ed. E.W. Jone, J.R. Pringle, and J.R. Broach), pp. 319-414. Cold Spring 
Habor Laboratory Press, Cold Spring Habor, N.Y. 
Hirst, M., Kobor, M.S., Kuriakose, N., Greenblatt, J., and Sadowski, I. 1999. GAL4 is 
regulated by the RNA polymerase II holoenzyme-associated cyclin-dependent protein 
kinase SRB10/CDK8. Mol. Cel/3: 673-678. 
Holstege, F.C., Jennings, E.G., Wyrick, J.J., Lee, T.l., Hengartner, C.J., Green, M.R., 
Golub, T.R., Lander, E.S., and Young, R .A. 1998. Dissecting the regulatory circuitry of a 
eukaryotic genome. Cell95: 717-728. 
Huddleston, M.J., Annan, R.S., Bean, M.F., and Carr, S.A. 1993. Selective detection of 
phosphopeptides in complex mixtures by electrospray LC-MS . .!. Am. Soc. Mass 
Spectrom. 4:710-717. 
Jackson, P.K., Eldridge, A.G., Freed, E., Furstenthal, L., Hsu, J.Y., Kaiser, B.K., and 
Reimann, J.D. 2000. The lore of the RINGs: substrate recognition and catalysis by 
ubiquitin ligases. Trends Cell Bioi. 10: 429-439. 
Kaffman, A., Rank, N.M., O'Neill, E.M., Huang, L.S., and O'Shea, E.K. 1998. The 
receptor Msn5 exports the phosphorylated transcription factor Pho4 out of the nucleus. 
Nature 396: 482-486. 
Kim, Y.J., Bjorklund, S., Li, Y., Sayre, M.H., and Kornberg, R.D. 1994. A multiprotein 
mediator of transcriptional activation and its interaction with the C-terminal repeat 
domain of RNA polymerase II. Ce/177: 599-608. 
Kornitzer, D., Raboy, B., Kulka, R.G., and Fink, G.R. 1994. Regulated degradation of the 
transcription factor Gcn4. EMBO .!. 13: 6021-6030. 
131 
Liao, S.M., Zhang, J., Jeffery, D.A., Koleske, A.J. , Thompson, C.M., Chao, D.M., 
Viljoen, M., van Vuuren, H.J., and Young, R.A. 1995. A kinase-cyclin pair in the RNA 
polymerase II holoenzyme. Nature 374: 193-196. 
Martinez-Pastor, M.T., Marchler, G., Schuller, C., Marchler-Bauer, A., Ruis, H., and 
Estruch, F. 1996. The Saccharomyces cerevisiae zinc finger proteins Msn2p and Msn4p 
are required for transcriptional induction through the stress response element (STRE). 
EMBO J. 15: 2227-2235. 
Meimoun, A., Holtzman, T., Weissman, Z., McBride, H.J., Stillman, D.J., Fink, G.R., 
and Kornitzer, D. 2000. Degradation of the transcription factor Gcn4 requires the kinase 
Pho85 and the SCF(CDC4) ubiquitin-ligase complex. Mol. Bioi. Cel/11: 915-927. 
Molinari, E., Gilman, M., and Natesan, S. 1999. Proteasome-mediated degradation of 
transcriptional activators correlates with activation domain potency in vivo. EMBO J. 18: 
6439-6447. 
Myer, V.E., and Young, R.A. 1998. RNA polymerase II holoenzymes and subcomplexes. 
J. Bioi. Chem. 273: 27757-27760. 
Natarajan, K., Jackson, B.M., Zhou, H., Winston, F., and Hinnebusch, A.G. 1999. 
Transcriptional activation by Gcn4p involves independent interactions with the SWI/SNF 
complex and the SRB/mediator. Mol . Cel/4: 657-664. 
Niederberger, P., Miozzari, G., and Hutter, R. 1981. Biological role of the general control 
of amino acid biosynthesis in Saccharomyces cerevisiae. Mol. Cell Bioi. 1: 584-593. 
Nishizawa, M., Kawasumi, M., Fujino, M., and Toh-e, A. 1998. Phosphorylation of sicl, 
a cyclin-dependent kinase (Cdk) inhibitor, by Cdk including Pho85 kinase is required for 
its prompt degradation. Mol. Bioi. Cel/9: 2393-2405. 
Patton, E.E., Willems, A.R., Sa, D., Kuras, L., Thomas, D., Craig, K.L., and Tyers, M . 
1998a. Cdc 53 is a scaffold protein for multiple Cdc34/Skp 1/F-box proteincomplexes that 
regulate ce11 division and methionine biosynthesis in yeast. Genes Dev. 12: 692-705. 
Patton, E.E., Willems, A.R., and Tyers, M. 1998b. Combinatorial control in ubiquitin-
dependent proteolysis: don't Skp the F-box hypothesis. Trends Genet. 14: 236-243. 
Pringle, J.R., Adams, A.E., Drubin, D.G., and Haarer, B.K. 1991. Immunofluorescence 
methods for yeast. M ethods Enzymol. 194: 565-602. 
132 
Schmitt, A.P., and McEntee, K. 1996. Msn2p, a zinc finger DNA-binding protein, is the 
transcriptional activator of the multistress response in Saccharomyces cerevisiae. Proc. 
Nat/. Acad. Sci. USA 93: 5777-5782. 
Schneider, B.L., Seufert, W., Steiner, B., Yang, Q.H., and Futcher, A.B. 1995. Use of 
polymerase chain reaction epitope tagging for protein tagging in Saccharomyces 
cerevisiae. Yeast 11: 1265-1274. 
Schwab, E ., Bohm, T., Mendenhall, M.D., and Nasmyth, K. 1994. The B-type cyclin 
kinase inhibitor p40SIC1 controls the G I to S transition in S. cerevisiae. Cel/79: 233-
244. 
Seol, J.H., Feldman, R.M., Zachariae, W., Shevchenko, A., Correll, C.C., Lyapina, S. , 
Chi, Y., Galova, M., Claypool, J., Sandmeyer, S. et al.. 1999. Cdc53/cullin and the 
essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates 
the E2 enzyme Cdc34. Genes Dev. 13: 1614-1626. 
Sherman, F. 1991. Getting started with yeast. Methods Enzymo/.194: 3-21. 
Skowyra, D., Craig, K.L. , Tyers, M., Elledge, S.J., and Harper, J.W. 1997. F-box proteins 
are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. 
Cel/91: 209-219. 
Thompson, C.M., Koleske, A.J. , Chao, D.M., and Young, R.A. 1993. A multisubunit 
complex associated with the RNA polymerase II CTD and TAT A-binding prote in in 
yeast. Cel/73: 1361-1375. 
Verma, R. , Annan, R.S. , Huddleston, M.J. , Carr, S.A., Reynard, G., and Deshaies, R.J. 
1997c. Phosphorylation of Sic 1 p by G 1 Cdk required for its degradation and entry into S 
phase. Science 278: 455-460. 
Verma, R., Chi, Y., and Deshaies, R.J. 1997b. Ubiquitination of cell cycle regulatory 
prote ins in yeast extract. Methods Enzymol. 283: 366-376. 
Verma, R., Feldman, R., and Deshaies, R.J. 1997a. SICI is ubiquitinated in vitro by a 
pathway that requires CDC4, CDC34, and cyclin/CDK activities. Mol. Bioi. CellS: 1427-
1437. 
Zhang, X., Herring, C.J., Romano, P.R. , Szczepanowska, J., Brzeska, H., Hinnebusch, 
A.G., and Qin, J. 1998. Identification of phosphorylation sites in proteins separated by 
polyacrylamide gel electrophoresis. Anal. Chem. 70: 2050-2059. 
133 
Chapter 4. Future directions: Ne~:ative re~:ulation of transcription 
factors throu~:h DNA bindin~: 
Introduction 
The primary task of a newly synthesized transcriptional activator is to activate the 
transcription of its target genes in the nucleus. Once it travels into the nucleus, the 
transcriptional activator effects gene-specific transcriptional activation in a series of steps 
as suggested by current models (Lee and Young 2000). The activator first binds to the 
regulatory elements of target genes. DNA binding of the activator then recruits 
chromatin remodeling and modifying complexes such as Swi/Snf and SAGA to 
promoters. Chromosomal remodeling may increase the stability of the activator-DNA 
complex or affect access of promoter sequences for binding of the transcription 
apparatus. Once the repressive effect of the nucleosomal structure is resolved, the 
activator then recruits the transcription initiation apparatus to promoters. This is 
probably achieved through interactions between the activation domain of the activator 
and the transcription apparatus, such as components of the RNA polymerase II 
holoenzyme. Finally, the activator stimulates the activity of the assembled transcription 
apparatus, resulting in robust transcriptional initiation of its target genes. 
Although activators may also influence the events subsequent to assembly of the 
initiation apparatus, the eventual fate of these activators is not clear. How long do they 
bind to the promoters, and how are they negatively regulated after they have performed 
their tasks? Recent evidence and studies in Chapter 3 suggest at least two modes of 
negative regulation of transcription factors: ubiquitin-dependent degradation (e.g. Gcn4) 
and nuclear exclusion (e.g. Msn2 and Pho4). The former appears to be mainly applicable 
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to short-lived transcription factors and the latter for relatively long-lived ones. Since 
there may be two different pools of transcription activators present in the nucleus, 
promoter-bound and free ones, an obvious question is: how are the different pools of 
activators regulated? The work described in Chapter 3 indicates that two different 
kinases (SrblO and Pho85) redundantly contribute to Gcn4 turnover. Given that SrblO 
CDK is part of the RNA Polymerase II holoenzyme, we initially hypothesized that the 
two kinases account for the degradation of different pools of Gcn4: whereas Srb I 0 
promotes the degradation of promoter-bound Gcn4, Pho85 targets primarily Gcn4 
molecules that are not bound to DNA. Here we show preliminary studies on the DNA-
binding mutants of Gcn4 and Pho4. Our results indicated that a DNA-binding mutant of 
Gcn4 was significantly stabilized compared to wild type Gcn4, suggesting that DNA 
binding is required for rapid Gcn4 turnover in vivo. This DNA-binding mutant of Gcn4 
was not further stabilized to appreciable extent in an srbl 011 or a pho85 11 mutant, 
suggesting that both kinases target promoter-bound Gcn4 for degradation. Finally, cells 
carrying a DNA-binding mutant of Pho4 showed predominantly nuclear localization of 
this protein under phosphate-rich conditions, suggesting that DNA binding is required for 
the nuclear export of Pho4. Taken together, we propose a general model that negative 
regulation of transcription factors is coupled to DNA binding. 
Preliminary Results 
Rapid degradation ofGcn4 in vivo requires DNA binding 
The finding that the Srb I 0 CDK phosphorylates Gcn4 and promotes its turnover 
raises an interesting possibility that this regulation may be confined to the vicinity of 
promoter DNA. To test this possibility, we constructed DNA-binding mutants of Gcn4 
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and tested their stability in vivo by pulse-chase analysis. A single point mutation 
(A238G) in the basic region of Gcn4 DNA-binding domain nearly eliminates the DNA-
binding of Gcn4 in vitro and its activity in vivo (Fig. I; Pu and Struhl 1991 ). Pulse-chase 
analysis of this DNA-binding mutant indicated that it had a half-life about 30 minutes 
compared to the wild type Gcn4, which had a half-life of about 2 minutes (Fig. 2). A 
similar result was obtained for another Gcn4 DNA-binding mutant (Gcn4-N235K, data 
not shown). This suggests that DNA binding is required for rapid Gcn4 turnover in vivo. 
Since CDK phosphorylation is also required for Gcn4 turnover (Chapter 3), we infer that 
the specific phosphorylation of Gcn4 that leads to its degradation requires DNA binding. 
Consistent with this, Srb 10-dependent phosphorylation of Gcn4 was reduced in a DNA-
binding mutant of Gcn4 as indicated by the change in the molecular weight (MW) up-
shifted form of Gcn4 (Fig. 2, compare lanes 1 and 9). The residual phospho-shift in 
Gcn4-A238G is SRBJO-dependent (data not shown) and may be due to the residual DNA 
binding of Gcn4-A238G because the activity of Gcn4-A238G was not completely 
eliminated in vivo (Fig.l, compare gcn4,1 with A238G). Alternatively, it may be due to 
phosphorylation of DNA-unbound form of Gcn4 by Srb 10. 
Both SrblO and Pho85 CDKs target DNA-boundform ofGcn4 for degradation 
We originally hypothesized that SrblO CDK and Pho85 CDK target different 
pools of Gcn4 for degradation. Specifically, we suspected that Pho85 may target a large 
pool of Gcn4 proteins that are not bound to DNA. To test this possibility, we measured 
the stability of Gcn4-A238G in srbl0-3 or pho85t1 strains. Interestingly, neither deletion 
of SRBJO nor deletion of PH085 further stabilized Gcn4 significantly (Fig. 3), suggesting 
that both kinases target primarily the DNA-bound form of Gcn4 for degradation. 
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DNA binding is required for nuclear exclusion of Pho4 
To test if DNA binding is a general requirement for the negative regulation of 
transcription factors, we investigated the regulation of the transcription factor Pho4, 
which is involved in phosphate metabolism (Oshima 1997). Unlike Gcn4, Pho4 is 
relatively stable and is regulated by localization (Komeili and O'Shea 2000). Under 
phosphate-rich conditions, Pho85/Pho80 CDK phosphorylates Pho4 and promotes its 
export from the nucleus (Kaffman et al. 1994; O'Neill et al. 1996). As a result, Pho4 
appears predominantly cytoplasmic when cells are grown in phosphate-rich medium. 
Based on the crystal structure of Pho4 bHLH domain-DNA complex (Shimizu et al. 
1997), we constructed a DNA-binding mutant of Pho4 (Pho4-db), which had three of its 
conserved base-contact residues mutated to alanine (H255A, E259A, R263A). We then 
looked at the localization of wild type Pho4 and Pho4-db by indirect 
immunofluorescence. If DNA binding is required for Pho4 export, we would predict a 
defect in the nuclear exclusion of Pho4 when cells are grown in phosphate-rich medium. 
As shown in Fig. 4, this was indeed the case: whereas wild type Pho4 was predominantly 
cytoplasmic in most cells, Pho4 was predominantly nuclear. 
Discussion 
Regulation of Gcn4 and Pho4 through DNA binding 
The preliminary results shown above suggest that the negative regulation of 
transcription activators may be coupled to DNA binding because transcription factors 
(e.g. Gcn4 and Pho4) are not subject to the tight regulation if they fail to bind DNA (Figs. 
2 and 4). Since phosphorylation of Gcn4 and Pho4 is required for their regulation but not 
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for their activity (Chapter 3; O'Neill et al. 1996), it is likely that DNA binding is required 
for the phosphorylation of Gcn4 and Pho4. Consistent with this, Srb 1 0-dependent 
phosphorylation of a DNA-binding mutant of Gcn4 is reduced compared to wild type 
(Fig. 2). Pulse-labeling or immunoblot experiments are needed to monitor the 
phosphorylation state of wild type Pho4 versus Pho4-db since Pho85-dependent 
phosphorylation of Pho4 in vivo causes electrophoretic mobility shift of Pho4 (Kaffman 
et al. 1998). The prediction is that Pho85-dependent phosphorylation seen for wild type 
Pho4 would be diminished for Pho4-db. Although more control experiments need to be 
done to solidify these preliminary findings, the combined results of Gcn4 and Pho4 
suggest a model that phosphorylation of transcription factors at the promoter DNA may 
serve as timers that restrict the amount of transcripts they can activate, and the substrate-
specific phosphorylation events lead to their inactivation by distinct means, including 
degradation and nuclear export (Fig. 5). 
Future directions 
Similar to Pho4, Msn2/Msn4, two partially redundant multistress transcription 
factors, are also regulated by localization (Chapter 3; Gomer et al. 1998). 
Phosphorylation of Msn2 by Srb 10 (Chapter3) and protein kinase A (Gomer et al. 1998) 
have been implicated in this regulation. We are currently constructing a DNA-binding 
mutant of Msn2 to test if DNA binding is also required for Msn2 regulation. 
Since Pho85 CDKs have been shown to negatively regulation of both Gcn4 and 
Pho4, an interesting possibility is that Pho85 CDKs may be localized to the vicinity of the 
DNA, or they may be recruited to DNA by transcription factors upon DNA binding. One 
can envision two possible mechanisms of how DNA binding mediates the regulation of 
Gcn4 and Pho4. One possibility is that DNA binding causes a conformational change in 
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Gcn4 and Pho4 that renders them better substrates for Pho85. The second possibility is 
that Pho85 is concentrated in the vicinity of DNA, and DNA-bound forms of Gcn4 and 
Pho4 have a better chance of being phosphorylated by Pho85. We are designing 
experiments to distinguish these possibilities. 
Immunopurified SrblO and Pho85 kinase activities are sufficient to phosphorylate 
Gcn4 in vitro (Chapter 3; Meimoun et al. 2000). If DNA-bound Gcn4 is the 
physiological substrate, one would expect that the rate of phosphorylation by these 
kinases may be greatly enhanced if the kinase assays are performed in the presence of 
DNA fragments containing Gcn4 binding sites. If so, phosphorylation pattern of wild 
type Gcn4 can be compared with that of DNA-binding mutant of Gcn4 to reveal critical 
site(s) whose phosphorylation is strongly DNA-dependent. 
Phosphorylation of Gcn4 by Pho85 CDK promotes its degradation whereas 
phosphorylation of Pho4 by Pho85 CDK promotes its nuclear export. An interesting 
question is why Pho85 CDK complexes regulate transcription factors by distinct means? 
How is the specificity achieved? The specificity may derive from the sequences 
surrounding the critical phosphorylation sites on the substrates, or it may have to do with 
the exact region in the nucleus where the phosphorylation occurs. Genetic results 
indicate that the Pho80/Pho85 is the only Pho85 CDK complex involved in Pho4 
regulation (Oshima 1997) whereas there may be multiple Pho85 CDK complexes 
involved in Gcn4 turnover, including Pc11 /Pho85 (Meimoun et al. 2000). Studies using a 
Gcn4-Pho4 hybrid protein may shed some light on this question. 
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Materials and Methods 
Yeast strains 
The yeast strains used in this study were derived from Z719 (MATa his3i1200 leu2-3,112 
ura3-52) and Z690 (MATa his3A200 leu2-3,112 ura3-52 srhl0-3::hisG) (Liao et al. 1995). 
Yeast cells were cultured in standard rich or synthetic medium supplemented with 2% 
dextrose as described (Sherman 1991). The GCN4 andPH04loci were modified to 
encode proteins tagged with nine copies of the myc epitope (myc9) at their C-termini as 
described (Seol et al. 1999). The gcn4 and pho85 deletion strains were generated by 
PCR-based one-step replacement (Baudin et al. 1993). Deletion alleles were confirmed 
by scoring mutant phenotypes and by PCR. The gcn4-A238G111·'.' 9 and pho4-dbmyc9strains 
were generated first by PCR-based site-directed mutagenesis using mutagenic oligos as 
previously described (Verma et al. 1997). DNA fragments containing the mutated coding 
sequences of GCN4 or PH04 were used to transform Z719 as described for wild type to 
generate myc9-tagged chromosomal alleles of these genes. All mutant alleles were 
confirmed by direct sequencing. Other derivative strains were constructed by genetic 
crosses. 
Pulse-chase experiments 
Cells were grown overnight in SD +leucine +histidine+ uracil at 30°C to mid-log 
phase (0D600 -0.5). Approximately 3 x 1 os cells were harvested and concentrated by 
centrifugation into 3 ml of the same medium. Cells were pulse-labeled for 5 min with 
500 !-!Ci of Tran35Slabel (1175 Ci/mmol, ICN), then chased in the same medium 
containing 1 mM ammonium sulfate, 5mM methionine and 1 mM cysteine. At various 
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times of the chase, 0.5 ml of the culture was removed and diluted immediately into I.5 ml 
cold stop buffer (50 mM Tris-HCl [pH7.5], 50 mM NaF and O.I% NaN3). Cells were 
centrifuged briefly and cell pellets were frozen in liquid nitrogen (and stored at -80°C if 
necessary). The cell pellets were then each supplemented with I 00 f.tl of 0.5 mm glass 
beads and IOO f.tllysis buffer (30 mM Tris-HCl [pH7.5], 0.5% SDS, 6% ammonium 
sulfate, 1 mM EDT A, 1 mM DTI and 0.5 mM PMSF), vortexed for 2 s, and boiled for 3 
min. The samples were cooled briefly, vortexed for 2 min, boiled again for 2 min and 
vortexed again for 1 min. Samples were then centrifuged at I 0,000 g for 10 min, and the 
supernatant was diluted five-fold with Triton buffer (30 mM Tris-HCl [pH7.5], 1% Triton 
X-1 00, I mM DTI and 1 mM PMSF) and immunoprecipitated with 9E 10 antibody and 
protein A beads. The protein A beads were washed three times with Buffer B, aspirated 
to dryness, and mixed with 2X Laemmeli buffer. Samples were boiled for 3 min prior to 
being evaluated by SDS-PAGE followed by autoradiography and Phosphorlmager 
(Molecular Dynamics) analysis. 
Immunofluorescence 
Cells were diluted from stationery culture ( 1 :500) and grown for 8-10 hr in l 0 ml 
YPD at 30°C to mid-log phase (OD600=-0.5). 1 ml of cells were then removed and fixed 
with 4.5% formaldehyde at room temperature for 30-45 min. Indirect 
immunofluorescence was carried out essentially as described (Pringle et al. 1991) using 
9E 10 (1 :3000) as primary antibodies and fluorescein-conjugated-goat-anti-mouse 
antibodies (1 :3000) as secondary antibodies. Zeiss Axiovision software was used to 
record digital images on a Zeiss Axioskop microscope. 
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Fig. 1 
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Figure 1. The A238G mutant of Gcn4 has diminished activity in vivo. 
(A) To test the activities of various Gcn4 derivatives in our strains, we employed a 
starvation plate assay similar to that described by (Natarajan et al. 1999). Cells were 
streaked on a control plate with normal leucine supplement and a plate with excess 
leucine, which causes isoleucine (lie) and valine (Val) starvation (Niederberger et al. 
1981 ). This assay monitors Gcn4-dependent activation of lie and Val biosynthetic genes. 
Specifically, Z719 (WT), gcn4111'Y9 ::URA3 (gcn411), and two isolates of gcn4-A238G111-'' 9 
(A238G) strains were grown on SD +leu (~0.23 mM) +his+ ura medium (control) and 
the same medium supplemented with 40 mM leucine (-lie,-Val) to induce starvation for 
isoleucine and valine. Plates were photographed after incubation at 30°C for 3 days. The 

























Figure 2. The A238G mutant of Gcn4 is stabilized in vivo. 
Pulse-chase analysis of Gcn4myc9 and Gcn4-A238Gmyc9 stability was carried out as 
described in Materials and Methods. Quantitation of the experiment was shown on the 
























Figure 3. Gcn4-A238G'"Yc9 is not further stabilized in an srbl 0-3 or a pho8511 strain. 
Same as Figure 2, except stability of Gcn4-A238Gmyc9 was measured in wild type, srbl 0-
3 , and pho8511 cells. Estimated half-lives (tl/2) of the mutant protein were shown on the 
right, and quantitation of the experiment was shown on the bottom. 
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Figure 4. A DNA-binding mutant of Pho4 is defective in its nuclear exclusion. 
Localization of Pho4myc9 and Pho4-dbmyc9 (H255A, E259A, and R263A) under phosphate-
rich conditions by indirect immunofluorescence with 9E I 0 antibody. DAPI was used to 
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Figure 5. A model for the negative regulation of transcription activators. 
An activator (factor X) enters the nucleus and binds to target DNA elements. DNA 
binding of the activator recruits the RNA polymerase II transcription initiation apparatus 
which contains the Srb 10 CDK, and it may also become accessible to other kinases such 
as the Pho85 CDK complexes. Transcription of the target gene is activated, and 
meanwhile the activator is phosphorylated by one or more of the kinases. Specific 
phosphorylation of the activator leads to either its degradation by a ubiquitin-dependent 
pathway such as SCF (e.g. Gcn4) or its nuclear export by a nuclear transport receptor 
such as Msn5 (e.g. Pho4) (Kaffman et al. 1998). 
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Appendix I. Polycation activation of Cdc34 
Results and discussion 
During the course of our investigation of Gcn4 ubiquitination in vitro, we 
identified an activity that stimulated Gcn4 ubiquitination in the absence of an E3 enzyme. 
This activity appeared to be heat-stable and fractionated in a low molecular weight range 
(~ 30 kDa). Since we used polyethyleneimine (PEl) in yeast extract preparations, we 
tested the trivial possibility that the stimulatory effect on Gcn4 ubiquitination might be 
provided by PEL 
We found that at low concentrations, PEl was indeed able to stimulate Gcn4 
ubiquitination in the absence of an E3 enzyme (Fig. 1 ). Gcn4 was not modified 
detectably in the presence of E 1, Cdc34, ATP, and ubiquitin (Fig. 6B, lane 2), but 
high-molecular-mass K48-linked multiubiquitin chains were assembled on Gcn4 upon 
inclusion of PEl (lanes 6,7). Thus, PEl acts like a classic E3. Together with the 
observation that polylysine activates the autoubiquitination of a C-terminally truncated 
form of Cdc34 (Seol et al. 1999), these results indicate that polycations can substitute for 
SCF. 
The ability of polycations to substitute for SCF strongly suggests that an E3-
linked ubiquitin thioester intermediate is not required to evoke the intrinsic ability of 
Cdc34 to assemble K48-linked multiubiquitin chains. It also sheds light on the potential 
mechanism of activation of Cdc34 by the Cdc53/Hrtl module. We propose that 
Cdc53/Hrtl stabilizes the oxyanion that is formed in the transition state as the carboxyl 
terminus of ubiquitin is transferred from Cdc34 to the £-amino group of a substrate 
lysine. Cdc53/Hrtl (or polycations) may directly provide a positive charge to neutralize 
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the oxyanion, or may elicit a favorable conformational change in Cdc34. Hrtl binds both 
Cdc34 and components of the SCF complex directly, placing it in an optimal position to 
coordinate the transfer of ubiquitin from Cdc34 to substrate. 
Materials and Methods 
Ubiquitination of Gcn4 in vitro 
Gcn4 was produced by in vitro translation in rabbit reticulocyte lysates and was partially 
purified by DEAE chromatography. Ubiquitination reaction was carried out in the 
presence of purified recombinant Ubal, Cdc34, wild-type ubiquitin (or His6-ubiquitin), 
or mutant ubiquitin derivative (His6-K48R ubiquitin ) as previously described (Chi et al. 
2001 ). Polyethyleneimine (PEl) was added to the final concentration of 0.0005% where 
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Figure 1. Polyethyleneimine is an E3 for Gcn4. 
35S-labeled Gcn4 produced by in vitro translation in reticulocyte lysate and enriched by 
DEAE chromatography was mixed withE 1, Cdc34, A TP, the indicated ubiquitin 
derivatives (lanes 4-6; H6 stands for His6) and 0.0005% polyethyleneimine (PEl), and 
incubated at 25°C for 60 min. Reactions conducted in the absence of either Cdc34, PEl, 
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Appendix II. Identification of Hrr25 as a Gcn4 kinase 
This work was done in collaboration with Edwin Carmack from John R. Yates's lab, who 
carried out the protein identifications by mass spectrometry. 
Results and discussion 
To identify activities required for Gcn4 ubiquitination in vitro, we fractionated 
yeast extracts and discover a novel kinase activity that promoted Gcn4 ubiquitination in 
vitro. We attempted to purify this activity by conventional column chromatography. Our 
initial purification effort was partly guided by the premise that there is only one major 
Gcn4 kinase in the cell and this kinase promotes Gcn4 ubiquitination. Due to technical 
difficulties and reagent limitations, we only monitored the kinase activity by kinase 
assays using purified recombinant Gcn4 expressed in E . coli as substrate. 
Following a purification scheme shown in Fig. 1, we were able to purify the 
kinase activity to near homogeneity and identify a protein band on a silver-stained SDS 
gel (Fig. 2A) that co-fractionated with Gcn4 kinase activity (Fig. 2C, D). This protein 
has a molecular weight (MW) of approximately 55-60 kDa as judged by its 
electrophoretic mobility on a SDS gel (Fig. 2A). The majority of the peak fractions from 
the Mono S column were pooled, concentrated, and fractionated by SDS PAGE. The gel 
was then stained with Coomassie Blue (Fig. 3). The Gcn4 kinase band ( ~ 1-2 f-l,g) was 
excised and subjected to mass spectrometry (MS) analysis. The MS analysis showed that 
the majority of the peptides correspond to a yeast protein called Hrr25, which is a Casein 
kinase I isoform. 
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Hrr25 has a molecular mass of about 57 kDa, consistent with the size of the 
protein we purified. Furthermore, purified recombinant GST-Hrr25 expressed in E. coli 
was able to phosphorylate Gcn4 with reasonable efficiency (data not shown), confirming 
that the kinase activity we purified from yeast extracts was due to Hrr25. 
To test if phosphorylation of Gcn4 by Hrr25 promotes its ubiquitination, we 
carried out Gcn4 ubiquitination using either 35S-labeled Gcn4 or E. coli-expressed Gcn4 
that was pre-phosphorylated with purified Hrr25 from yeast. In the presence of E1, 
Cdc34, and SCF (Cdc53/Cdc4/Skp 1 triple infection), we did not observed any Gcn4 
ubiquitination (data not shown). This suggests that phosphorylation of Gcn4 by Hrr25 is 
not sufficient to promote Gcn4 ubiquitination. 
After the identification of Srb 10 as a Gcn4 kinase and the availability of SCF 
preparations containing the Hrt1 subunit, we pre-phosphorylated E. coli-expressed Gcn4 
using either immunopurified SrblO (control) or recombinant GST-Hrr25 and carried out 
Gcn4 ubiquitination in the presence of purified scpCdc4 containing Hrtl. As shown in 
Fig. 4, SrblO-phosphorylated Gcn4 was ubiquitinated to high efficiency as evidenced by 
the accumulation of high MW ubiquitin conjugates and the disappearance of the input 
substrate (lane 2). In contrast, Hrr25-phosphorylated Gcn4 was only ubiquitinated to a 
small extent, and there is no apparent high MW ubiquitin conjugates (lane 4). It is also 
possible that these low level of ubiquitination of Gcn4 is independent of phosphorylation 
by Hrr25 because phosphorylation-dependence was not addressed in this assay. 
Nevertheless, it is clear that phosphorylation of Gcn4 by Hrr25 does not make it a 
efficient substrate for ubiquitination by Cdc34/SCFcdc4 • 
Hrr25 is a casein kinase I isoform that play multiple roles in cellular metabolism 
and regulation. It was originally identified as a kinase that might play a role in DNA 
damage repair (Hoekstra et al. 1991 ). It was later found to be a dual specificity kinase 
(Hoekstra et al. 1994). Although HRR25 is not essential, hrr2511 cells have extremely 
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slow growth under normal conditions in rich media, suggesting that Hrr25 is necessary 
for the normal rate of cell growth. To date, the exact functions of Hrr25 have not been 
elucidated, and genetic analyses have implicated several different functions of this 
protein. We identified Hrr25 as a potent Gcn4 kinase in yeast extracts. We do not yet 
know if Hrr25 is a physiological kinase for Gcn4 in vivo, and there is no genetic evidence 
linking Hrr25 to Gcn4. Determination of the potential role of Gcn4 phosphorylation by 
Hrr25 would require mapping and mutating Hrr25-dependent phosphorylation sites on 
Gcn4. 
Although phosphorylation of Gcn4 by Hrr25 does not make Gcn4 a good 
substrate for SCFcuc4 (Fig. 4), this demonstrates that the phosphorylation events that 
render Gcn4 competent for efficient ubiquitination by scpeuc~ is highly specific. In this 
case, CDK phosphorylations are likely the prominent signals that trigger efficient 
ubiquitination of Gcn4 by Cdc34/ scpCdc4 . 
Methods 
Purification ofGcn4 kinase activity 
The purification scheme of the Gcn4 kinase activity is outlined in Fig. I. 8 L of RJD 481 
cells were grown to OD600 of 3-4 and harvested. Whole cell extract (WCE) was prepared 
as previously described (Chi et al. 2001 ). 150 mL of WCE (- 2 g total protein) was first 
fractionated by ammonium sulfate precipitation. The 0-40% ammonium sulfate pellete 
was resuspended in 50 mL CWB (50 mM NaCl; 25 mM Tris-HCl, pH 7.6; 1 mM DTT) 
and dialyzed in the same buffer. The entire volume (-350 mg total protein) was then 
loaded onto a 10 mL phosphocellulose column. The kinase activities were eluted with a 
0.2-0.5 M NaCl gradient and evaluated by Gcn4 kinase assay. Peak fractions were 
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pooled and dialyzed against CWB. The final pooled fraction (~ 15 mg total protein; 37 
mL) was loaded onto a 3 mL GST -Gcn4 affinity column (prepared by binding of GST-
Gcn4 to glutathione agarose beads at~ 2mg/mL). Gcn4 kinase activities were eluted 
with a 0.1 M to 0.6 M NaCl gradient. Peak fractions were pooled and diluted with low 
salt buffer. The final fraction (- 1 mg total protein; 10 mL) was loaded onto a 1 mL 
Mono Q column for FPLC (Pharmacia). Gcn4 kinase activities were eluted with a 0.15 
M to 0.5 M N aCl gradient. Peak fractions (~ 100 f!g total protein; 3 mL) from Mono Q 
were pooled, diluted with low salt buffer, and loaded onto a 0.1 mL Mono S PC column 
(Pharmacia). Gcn4 kinase activities were eluted with a 0.125 M to 0.55 M NaCl 
gradient. Most of the peak fractions were pooled, concentrated, and fractionated on SDS 
PAGE. The SDS gel was visualized by Coomassie and the kinase band was cut out for 
mass spectrometry analysis. One peak fraction was further fractionated on a Superdex 
200 PC column (Pharmacia), and the co-fractionation of the kinase and the Gcn4 kinase 
activity was confirmed (Fig. 2). 
Gcn4 kinase and ubiquitination assays 
Gcn4 kinase and ubiquitination assays were carried as previously described (Chi et al. 
2001). GST-Hrr25 was expressed in E. coli and purified by affinity chromatography 
using glutathione agarose (Sigma). 
Fig. I 
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Figure 1. Gcn4 kinase purification scheme. 
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Figure 2. Co-fractionation of the Gcn4 kinase with its activity. 
(A) Silver staining of protein fractions from the Superdex 200 step in Fig 1. Note that the 
fractions were collected in the vicinity of the anticipated MW range of the kinase activity 
in this experiment. The arrow points at the protein band that correspond to the purified 
Gcn4 kinase. 
(B) 32P Gcn4 kinase assay was carried to measure the kinase activity of each of the 
fractions. 
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Figure 3. Coomassie staining of the purified Gcn4 kinase. 
Most of the peak fractions of the Mono S step (Fig. 1) were pooled, concentrated, and 
loaded onto a large SDS gel. The protein bands were visualized by Coomassie staining. 
The band corresponding to the kinase was marked by the arrow. 
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Fig. 4 
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Figure 4. Ubiquitination of phosphorylated Gcn4. 
Equal amount (- 1 ~-tg) of recombinant Gcn4 was first phosphorylated by either 
immunopurified SrblO kinase or purified recombinant GST-Hrr25 expressed in E. coli. 
Phosphorylated Gcn4 (input; note the similar amount of 32P incorporation) was then 
incubated with a ubiquitination reaction mix containing El, Cdc34, ubiquitin and purified 
recombinant scpCdc4 complex (quadruple infection) (complete). Reactions were 
visualized by SDS PAGE followed by autoradiography. 
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